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Eukaryotic K+ channels from the SLO family (SLO1, SLO2 and SLO3) provide a
link between intracellular signaling and the electrical activity of a cell. The
opening and closing (gating) of the three different SLO homologs is controlled by
the synergistic action of membrane voltage and specific intracellular cues: Ca2+
binding in SLO1, Na+ binding in SLO2 and pH increase in SLO3. It is known that
intracellular signals activate SLO channels by acting on the large cytoplasmic
domains (CTDs) of these proteins, which follows the transmembrane ionconduction pore. However, a molecular description of the mechanisms of
intracellular gating in SLO channels is still lacking.
In this thesis, I present biochemical, structural and functional studies
aiming at understanding how the activity of SLO1 and SLO3 channels is
controlled by intracellular Ca2+ binding and pH increase, respectively. First, I
describe recombinant methods for the large-scale expression and purification of
functional SLO channels, paving the way for a more complete biochemical and
structural analysis of these proteins. Then, I report the crystal structures of the
large cytoplasmic domains (CTDs) from two different SLO1 channels. Structures
of the Ca2+-bound CTDs from human and zebrafish SLO1 channels define the
precise molecular architecture of SLO1’s Ca2+-sensing module: CTDs from the
four subunits of a tetrameric SLO1 channel assemble in a so-called gating ring

structure at the intracellular face of the membrane. In conjunction with other
studies, these results describe how Ca2+ binding affects the conformation of one
layer of the SLO1 gating ring, which can explain the Ca2+-driven opening of
SLO1’s ion conduction pore. Next, I present the crystal structure of the human
SLO3 gating ring. A comparison with the SLO1 structures suggests that the
hSLO3 structure represents the open conformation of the hSLO3 gating ring.
Finally, I describe functional mutagenesis studies on the mouse SLO3 ortholog,
which reveal a possible mechanism for pH sensing in the mouse SLO3 channel.
Surprisingly, the mechanism I propose appears not to be conserved in SLO3
channels from other species. This could be a dramatic example of how new
functional mechanisms can easily evolve within the very versatile scaffold of a
gating ring structure.
Altogether, the results presented in this thesis provide a molecular
framework to understand the mechanisms of intracellular gating in SLO
channels.
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CHAPTER ONE:

INTRODUCTION
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Living cells are sophisticated information-processing machines. In order
to perform the essential functions of survival of the organism or transmission of
genetic material, a cell must perceive and process information about both its
environment and its own physiological state. Within the cell, a wide range of
signals acting in concert allow this information to be integrated and transmitted,
to ultimately coordinate the action of the various cellular components that will
elicit an appropriate response. One of the most ubiquitous forms of cellular
signaling is electrical in nature: by controlling the distribution and movement of
ions (that is, electric charges), a cell can encode signals in the form of a voltage
across the lipid membrane surrounding it. This voltage can in turn be sensed by
specialized proteins in the cell to regulate their activity.
At a very general level, the work presented here aims at understanding
some specific aspects of how electrical signaling is used and controlled in cells. I
studied a family of eukaryotic proteins called the SLO potassium channels,
which regulate the electrical activity of a cell in response to an intracellular
stimulus. In a sense, SLO channels translate information about intracellular
activity into electrical signaling. The main question I am interested to address is
how this translation occurs at the molecular level, in other words by which
mechanisms intracellular activity modulates these proteins in order to control
their function.
To appreciate the biological role of SLO channels, I will start by
introducing the basic principles of electrical signaling in cells. I will then present
in detail the SLO family of K+ channels, insisting on their physiological roles and
functional properties. I will finish this introduction by describing my research
project and the motivation for my work.
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1.1 - ELECTRICAL SIGNALING IN CELLS AND ION CHANNELS

1.1.1) “Animal electricity”
Electricity is an essential part of life’s toolbox. For example, the electrical
signals that we can visualize in an electrocardiogram control our heartbeats.
Which form, then, does electricity take in a living cell?
Any electrical phenomenon is intrinsically linked to the movement of
electric charges. In biology, these charges are the inorganic ions (mostly: Na+, K+,
Ca2+ and Cl-) present in the aqueous environment that makes up the interior and
the surroundings of living cells (1, 2). As first envisioned by Julius Bernstein in
the very beginning of the 20th century (3), it is the controlled movement of these
ions in and out of cells that generates electrical signals (1, 2). In addition to
inorganic ions, life’s electrical system is based on three essential components: the
hydrophobic cell membrane, and two classes of proteins called ion pumps (also
called ion transporters) and ion channels (Figure 1). The cell membrane is a thin
oil-like lipid bilayer that separates the cell’s interior from its environment. The
hydrophobic character of the membrane forbids the free crossing of most
components of cells and their external milieu, in particular ions. The movement
of ions across the membrane is carried out by proteins embedded in and
spanning through the lipid bilayer: ion pumps and ion channels (1, 4). Ion
pumps use energy to force the transport of ions in one specific direction, and
thus generate concentration gradients across the membrane. Ion channels, which
are the focus of my work, do not use energy and are therefore passive pores in
the membrane that can only let ions diffuse along their (electro)chemical gradient
(5).
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Figure 1: The molecular components of life’s electrical system. Two kinds of proteins
embedded in the cell membrane control the movement of ions. Pumps use energy to
create ionic concentration gradients, while channels are passive pores letting ions flow
down their electrochemical gradients.
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1.1.2) Ion channels are at the core of the cell’s electrical network
Electrical signals in cells are encoded in the form of a voltage (difference
of electric potential) across the membrane. To act as a signal, the transmembrane
voltage must satisfy two essential criteria: it should be 1) precisely controllable
and 2) able to influence downstream effectors. The dynamic control of the cell’s
voltage arises from two central properties of ion channels: selectivity and gating.
Most channels are selective: they only allow a specific type of ion to cross
through their pore, excluding others. When an ion channel opens, the membrane
voltage at equilibrium is set at the reversal potential, i.e. the point at which
diffusion and electric driving forces commanding ion flow exactly balance each
other. For a selective ion channel, Nernst’s law of electrodiffusion shows that this
reversal potential is determined solely by the ratio of ion concentration outside
vs. inside the cell (Figure 2a). The action of dedicated pumps ensures that these
concentration ratios are different for Na+, K+, Ca2+ or Cl- ions. Selective channels
for each of these ions exist, such that the opening of a Na-, K-, Ca- or Cl-selective
channel sets the membrane voltage at different values (Figure 2b) (1, 2). Nonselective cation channels, which do not discriminate between cations but prevent
the conduction of anions and reverse at 0 mV, form another important class of
channels. At rest, the cell is polarized: the voltage is more negative inside
(typically -70 mV in animal cells) due to the opening of K+ and Cl- channels (2, 68). During activation or signal transmission, the membrane voltage becomes less
negative (depolarization) owing to the action of Na+, Ca2+ or non-selective cation
channels (1, 2, 9). When multiple channels are opened at once, each specific
channel type drives the membrane voltage towards its own reversal potential,
and the overall potential depends on the number and strength of each individual
conductance. Hence, by controlling the opening of particular kinds of selective
ion channels, cells can modulate the value of the transmembrane voltage and
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2a

Nernst equation for ion X:
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2c

Figure 2: The different reversal potentials of selective ion channels allow information
to be encoded in the membrane voltage. 2a) The ratio of ionic concentration across the
membrane sets the reversal potential (Erev) of a selective ion channel according to the
Nernst equation (R: gas constant; T: temperature; z: ionic charge; F: Faraday constant).
2b) This ratio varies for the different ionic species in a cell (Na+, Ca2+, K+, Cl-), so that the
reversal potential of the corresponding selective ion channels are different (values are
given for a typical mammalian skeletal muscle cell). 2c) Opening of specific selective
channels controls the membrane voltage, allowing information to be encoded (showing
the example of sequential openings of K+-, Na+-, Cl-- and Ca2+- selective channels).
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encode information (Figure 2c). This is another essential functional feature of ion
channels, known as gating: channels respond to specific signals that govern their
opening and closing. Multiple modes of gating exist, ranging from binding of a
ligand to the action of light (1).
In essence, ion channel gating mediates the tuning of the membrane
voltage to encode information. Downstream, the transmission of these signals is
ensured by specialized membrane proteins that can sense the voltage and
modulate their activity in response to it. These proteins are said to be voltagedependent, and in fact the most ubiquitous voltage-dependent proteins are ion
channels themselves (1, 10). The interplay between membrane voltage and
opening of voltage-gated channels is the basis for the conduction of action
potentials, first described in the seminal work of Hodgkin and Huxley (11).
However, voltage sensing is not restricted to channels, as demonstrated by the
recent discovery of Ci-VSP, a phosphatase enzyme whose activity is governed by
membrane voltage (12).

1.1.3) Electrical signaling is ubiquitous
Historically, the study of electrical signaling focused on tissues like nerves
and muscles where electrical phenomena manifest themselves perhaps the most
obviously. Neurons or muscle fibers belong to the family of excitable cells, in
which activity is controlled by the propagation of action potentials (1). The
outcome of action potential propagation is the opening of voltage-gated Ca2+
channels, and the subsequent entry of Ca2+ is the trigger for the main functional
response of excitable cells: release of synaptic vesicles in neurons, or
actin/myosin sliding in muscular fibers, for example.
Nonetheless, the basic components of the cellular electrical system are
present in virtually every cell type and every organism. In particular, voltage-
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gated proteins are ubiquitous (1, 6, 13). Since the core function of these proteins
is to sense variations in the membrane voltage, their ubiquity mirrors the
universality of electrical signaling in nature. For example, as I will discuss later,
one of the proteins I studied extensively is specific to sperm cells. Moreover,
electrical signaling is not restricted to animal cells and is used by plants as well
as unicellular organisms, often to allow a rapid response to environmental
changes (1). Examples include the folding of Mimosa leaves upon touch (14, 15)
or the obstacle avoidance response in Paramecium (16). Recently, the discovery of
rhythmic variations in the membrane voltage of the bacterium Escherichia coli
suggests that electrical signaling might be a very ancient form of functional
regulation in cells (17).

Altogether, electrical signaling – that is, encoding of information in the
form of a voltage across the cell membrane – is central to many aspects of cellular
physiology. Since the opening and closing of specific ion channels controls the
membrane voltage, understanding how ion channels gate is a key step towards
understanding the cellular responses governed by electrical signaling, from
information processing in the brain to the ability of a sperm cell to fertilize an
egg. Understanding how ion channels gate is precisely my interest. My main
focus is the study of a family of eukaryotic K+ channels called SLO, which
regulate many cellular functions, which I will describe in the next section.
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1.2 – THE SLO FAMILY OF K+ CHANNELS: PHYSIOLOGY

1.2.1) Overview of the SLO family of K+ channels
SLO channels are K+-selective pores expressed in animal cells, and are
gated by both membrane voltage and intracellular signaling. Since K+ ions are
more concentrated inside the cell than outside, opening of a SLO channel
hyperpolarizes the membrane and moderates the overall electrical activity of a
cell. Three types of SLO channels exist (SLO1, SLO2 and SLO3), which vary by
the kind of intracellular cue responsible for their activation (Figure 3a). SLO1,
SLO2 and SLO3 are activated by the binding of intracellular Ca2+, intracellular
Na+ or an increase in intracellular pH, respectively (18). Figure 3b shows the
basis of SLO1 activation by membrane voltage and intracellular Ca2+: voltage
and Ca2+ act in synergy to open the SLO1 pore. The same basic principle applies
to the activation of SLO2 and SLO3 by voltage and Na+ or alkalization,
respectively.
The activation of SLO1, SLO2 and SLO3 by different intracellular signals
underlies the fundamentally different functional roles these proteins play in cells.
These differences are reflected in the modest conservation of amino acid
sequence between the three homologs (Figure 3a). Especially, SLO2 is quite
divergent from SLO1 and SLO3, which are much closely related in sequence and
number of transmembrane helices (see below). Nonetheless, the three members
of the SLO family share common core properties.
First of all, all SLO channels share the same basic architecture (Figure 4).
As most K+ channels, SLO channels are homo-tetramers in the membrane (19,
20). The transmembrane pore of one protomer contains six transmembrane
helices (S1-S6), similar to canonical voltage-gated K+ channels: S1 to S4 make up
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3a

3b

Figure 3: SLO channels: activation and phylogeny. 3a) SLO1, SLO2 and SLO3 are
activated by different intracellular signals. The phylogenic relationship shown at the
bottom right can be inferred by comparing the sequences of the three homologs. 3b)
Activation of SLO1 by voltage and Ca2+: the channel’s open probability is shown as
function of intracellular Ca2+ concentration and membrane voltage (adapted from 224).
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the unit responsible for voltage sensing (at least in SLO1 and SLO3), whereas S5
and S6 form the pore responsible for ion flow (21). SLO1 and SLO3 (but not
SLO2) possess an additional transmembrane N-terminal helix, S0 (22). Following
S6, all three channel types have a large cytosolic domain that controls
intracellular activation (18, 23). This CyTosolic Domain, or CTD, is made of a
tandem of so-called RCK domains: RCK1 and RCK2 (24).
Another similarity arises from the main functional role of SLO channels in
cells: SLO channels act as negative feedback switches to regulate the intracellular
concentration of the same ions that activates them. This is best described for the
Ca2+-activated SLO1 (25, 26). Functional and biochemical studies have
established that SLO1 co-localizes with voltage-dependent Ca2+ channels in most
cell types (25-29). When the cytosolic Ca2+ concentration rises, SLO1 opens and
the resulting hyperpolarization drives the closing of voltage-gated Ca2+ channels
in the plasma membrane, thereby shutting off one of the main source of Ca2+
entry into the cytoplasm (Figure 5). Overall, the Ca2+-driven opening of SLO1
results in a decrease of intracellular Ca2+ itself. The precise mode of action of
SLO2 and SLO3 is less well characterized, but it is very likely that the same
negative feedback interplay exists between SLO2 and voltage-gated Na+ channels
or SLO3 and voltage-gated proton channels, both pairs being known to be
expressed in the same cell types (30-32).

1.2.2) SLO1 (BK, Maxi-K) channels
SLO1 channels (also known as BK or Maxi-K) were the first of the SLO
family to be discovered and characterized. Following the finding that internal
Ca2+ could activate potassium flux in tissues (33), the development of patchclamp and reconstitution techniques lead to the identification of a specific kind of
Ca2+-activated K+ channel with an unusually large unitary conductance (~100-300
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Figure 4: Conserved architecture of SLO channels. The topology of a SLO subunit is
shown on the left (the S0 transmembrane helix is not present in SLO2). The voltage
sensor, pore, RCK1 and RCK2 domains are shown in orange, green, blue and red
respectively. In the membrane, four identical subunits assemble in a tetrameric channel
(right, same color-code as previously). The voltage sensors from the front and back
subunits are not drawn for clarity.

Figure 5: SLO / voltage-gated channel negative
feedback interplay. 3a) SLO1 opening inhibits
voltage-gated Ca2+ channels by hyperpolarizing
the membrane, thereby shutting off one of the
main sources of Ca2+ entry in the cytoplasm. 3b)
The same interplay is likely to exist between SLO2
and voltage-gated Na+ channels, or SLO3 and
voltage-gated H+ channels.

3b)
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3a)

pS in symmetrical 150 mM K+, to be compared to ~25 pS for the archetypical
Shaker delay-rectifier K+ channel) (34, 35). This property gave the protein its
name: BK (for Big-K) or Maxi-K (36, 37). A mutation at the slowpoke locus was
discovered in Drosophila that abolishes BK currents in the fly muscles (38), paving
the way for the molecular cloning of the corresponding gene, slo (39-41). After
the discovery of the related SLO2 and SLO3 channels, BK was renamed SLO1,
which is the nomenclature I will be using here (18).
SLO1 channels are expressed throughout the animal kingdom (Metazoa).
SLO1 has a remarkably wide range of expression in human tissues, including
neurons, smooth and skeletal muscles, endocrine cells, kidney, pancreas or even
cartilage. Looking specifically in the brain, immunocytochemistry studies in mice
detected SLO1 expression in almost all brain regions (42). The ubiquity of SLO1
in different cell types likely reflects the universal physiological importance of
Ca2+ signaling (43-45). In excitable cells, where its function is best characterized,
SLO1 is involved in controlling neuronal activity, neurotransmitter release,
smooth and skeletal muscle tone or hair cell tuning, all of which involve Ca2+
entry through voltage-gated Ca2+ channels (18, 27, 46-52). The role of SLO1 in
non-excitable cells is less well established, but recent studies have proposed that
SLO1 currents, by hyperpolarizing the cell, regulate the driving force for Ca2+
influx through the plasma membrane or from intracellular stores (53, 54). The
wide physiological importance of SLO1 is reflected in the range of phenotypes of
SLO1 knock-out (KO) mice: KO animals are viable but exhibit ataxia, impaired
vasodilatation and vascular hypertension, incontinence, high-frequency hearing
loss and erectile dysfunction (55-59).
The diversity of cellular functions involving SLO1 is also mirrored by a
large array of physiological processes that regulate the channel’s properties. The
functional characteristics of SLO1 currents are modulated extensively by
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alternative splicing, complex phosphorylation, lipidation and binding of
cofactors (18, 60-64). Another level of complexity arises from the interaction of
SLO1 with other proteins in the cell. In particular in tetrapods (including
mammals), SLO1 is associated with a class of proteins known as β-subunits
which significantly alter its function (26). The first β-subunit, β1, was originally
identified in smooth muscles where it co-purifies with SLO1 (65, 66). The
elucidation

of

β1’s

primary

sequence

revealed

that

it

contains

two

transmembrane helices linked by a large, glycosylated extracellular loop (67),
and allowed the cloning of three other kinds of β-subunits based on sequence
similarity (β2, β3, β4) (68-73). β-subunits affect SLO1 function in different ways:
β1, β2 and β4 modulate both voltage-gating, apparent Ca2+ sensitivity and
activation/deactivation kinetics (73-76), and β2 and β3 confer fast inactivation
through a ball-and-chain mechanism (68, 69, 77). The phenotypes of KO mice for
β1 and β4 emphasize the functional importance of β-subunits, showing impaired
vasoregulation, bladder contraction and airway dilation for β1 (78-81), and
increased hippocampal activity for β4 (82). β-subunits are not the only proteins
known to interact with SLO1 (18, 60). In particular LRRC26, a leucine-rich repeatcontaining (LRRC) protein, has been recently described to dramatically activate
SLO1 currents in prostate cancer cells (83). The discovery that a related LRRC
protein also activates SLO3 raises the interesting possibility that members of this
protein family are general interacting partners of SLO channels (83).
Taken together, the vast diversity of modifications and interactions that
regulate SLO1 explains how the functional characteristics of SLO1 currents are
fine-tuned in different cell types (18). A fascinating example of how subtle
variations of SLO1 properties are important for cellular function is found in the
cochlea, where the expression of different SLO1 splice variants and the gradual
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expression of β1-subunits define the precise electrical resonant frequency at
which individual hair cells are set to respond (50).

1.2.3) SLO2 (Slick, Slack) channels
Expression of Na+-activated K+ channels (KNa) is well established in the
animal nervous system, from arthropods to mammals (30, 84). Their presence has
also been suggested in mammalian muscles, but might be species-specific (see for
example (85)). In neurons, KNa function is intimately linked to the excitatory
entry of Na+ during synaptic transmission or action potential propagation, and
KNa currents have been shown to regulate the shape of the action potential, the
firing rate of neurons or the kinetics of excitatory synaptic response (30, 31, 84,
86-88).
The vast majority of KNa channels are believed to be encoded by Slo2 (30).
SLO2.2 (also known as Slack) was first cloned based on sequence similarity with
SLO1 (89), and was later shown to be activated by intracellular Na+ (90). The
SLO2.1 (Slick) paralog was subsequently discovered based on sequence
homology (91). Both SLO2.1 and SLO2.2 are Na+-activated, but vary in their
functional details: SLO2.1 opens rapidly, is also activated by intracellular Cl- and
inhibited by ATP binding, whereas SLO2.2 displays slow “on” kinetics, is weakly
Cl--dependent and insensitive to ATP (30, 91). Immunocytochemistry and in situ
hybridization experiments in rat showed that SLO2.1 and 2.2 are widely
expressed in the brain, in particular in the olfactory bulb, visual and
somatosensory cortex, midbrain, hippocampus and brainstem (89, 92, 93). The
distribution of SLO2 matches the known abundance of KNa currents in the
nervous system, reinforcing the idea that most native KNa are encoded by SLO2
(30). However, the lack of specific pharmacological agents for SLO2 has hindered
the precise functional characterization of SLO2 channels in tissues.
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1.2.4) SLO3 (KSper) channels
The third member of the SLO family is present only in mammals, and is
specific to sperm cells (94). SLO3 is activated by membrane voltage and
intracellular alkalinization (94, 95). The pH-dependence of SLO3 reflects the fact
that intracellular pH (pHi) is a master regulator of activity in mammalian sperm.
pHi increase activates two essential properties of sperm cells: their motility (i.e.,
the ability to reach the egg) and their capacity of fertilization (i.e., the ability to
break through the egg’s membrane and deliver DNA) (32). From the testis to the
ovaries, sperm cells experience a gradual increase in extracellular pH, which
translates into an increase in pHi owing to the action of proton pumps and
proton channels in the mammalian sperm membrane (32, 96).
Voltage-sensitive ion channels in sperm cells are involved in both
regulating and sensing variations of pHi. In human sperm cells (but not in mice),
the voltage-gated proton channel Hv1 is a key regulator of pHi (32, 97, 98).
Furthermore, one of the direct effect of pHi increase is the opening of pHdependent voltage-activated Ca2+ channels (CatSper, described in mouse and
human sperm), which controls many aspects sperm activation (98-100). Hence,
pHi and electrical signals are intimately linked in the physiology of sperm cells.
To date, SLO3 function has been almost exclusively studied in mice,
although its expression in human sperm has been shown at the RNA level (94).
Electrical recordings of mouse sperm cells using the patch-clamp technique
revealed the existence of an alkaline-activated K+ current (KSper) (101), which
was later shown to be carried by SLO3 channels (102-104). Genetic knock-out
studies in mice highlighted the physiological importance of SLO3 in male
fertility. SLO3 KO mice are completely infertile under natural conditions, and
KO

sperm

cells

show

morphological

defects,

impaired

motility

and

compromised ability to undergo the acrosome reaction (103, 104). Importantly,
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fertilization with KO sperm cells could be achieved in vitro, but with much lower
rate of success than with wild-type cells (103, 104). Another interesting aspect of
the KO phenotype relates to the response of sperm cells to osmolarity changes.
Upon ejaculation, mammalian sperm cells must adapt to a decrease in
extracellular osmolarity, and one study showed that the motility and
morphological defects of SLO3 KO cells are exacerbated at low osmotic
conditions, raising the possibility that SLO3, on top of its role in controlling the
electrical balance of sperm cells, might also act as an osmoregulator (104).
Finally, as in the case of SLO1, SLO3 function is likely to be regulated by
transmembrane interaction partners in cells. The SLO1 β-subunit β4 is expressed
in mouse sperm, and might act as a chaperone for SLO3, increasing SLO3 surface
expression without significantly modulating its functional properties (105).
Recently, LRRC52, a newly discovered protein from the leucine-rich repeat
containing family, has been reported to co-assemble with SLO3 in mouse sperm
and to potentiate the pH sensitivity of SLO3 currents when expressed in
heterologous systems (106).

1.2.5) SLO channels as therapeutic targets
Owing to their diverse physiological roles, SLO channels have long been
recognized as important drug targets (107-110). In particular, the ubiquitous
importance of SLO1 in smooth muscle physiology makes it an attractive
candidate for the treatment of a wide range of disorders such as asthma,
hypertension, urinary incontinence or erectile dysfunction (110). This is further
emphasized by the discovery that human genetic variations in the SLO1 β1subunit cause asthma (111) or can directly affect blood pressure regulation (112).
Interestingly, some drugs currently on the market have been shown to act
through molecular pathways dependent on SLO1: examples include β-adrenergic
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agonists used for the treatment of asthma (113, 114), or phosphodiesterase
inhibitors (e.g. Viagra) used against erectile dysfunction (115). In addition, SLO1
has also recently emerged as a regulator of different kinds of human cancers, and
in vitro experiments have shown that SLO1 blockers can inhibit the proliferation
of specific types of cancer cells (116, 117).

Overall, the physiological roles of SLO channels in cells highlight the
central importance of intracellular activation for their function: these channels
are expressed in cells where changes in intracellular Ca2+, Na+ or pH are essential
for activity. Moreover, the conserved architecture of SLO channels suggests
similarities in their mechanism of action. My thesis work aims at understanding
how SLO channels’ function is regulated at the molecular level, and in particular
probing how the effects of the Ca2+, Na+ or pHi translate into channel opening. In
the next section, I will describe in more details our molecular and mechanistic
understanding of SLO channels’ function.
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1.3 – SLO CHANNELS: FUNCTIONAL MECHANISMS

1.3.1) Domain architecture
What is already known about the mechanisms of SLO channel activation
at the molecular level? In the absence of detailed atomic structures of SLO
channels, it is difficult to understand precisely the molecular events leading to
channel opening. However, insights about SLO channels’ structure and
mechanism can be drawn from the known structure of evolutionarily related K+
channels, which I will detail in this section (for excellent reviews, see (118) and
(21)).
As we have seen, each subunit of a tetrameric SLO channel can be divided
into three functional domains: the voltage sensor and the pore embedded in the
lipid bilayer, and the CyToplasmic Domain (CTD) (Figure 6). The pore is the
basic unit of ion conduction and selectivity, and contains the channel’s activation
gate. Channel opening and closing is ultimately controlled by conformational
changes happening in the pore. The function of the gating modules, voltage
sensors and CTD, is to sense gating signals and transfer the corresponding
energy to the pore domain to trigger opening in an allosteric manner. The pore,
voltage sensor and CTD domains are related to different classes of channels for
which structural data are available, and which shed light on the structure and
function of SLO channels.

1.3.2) Pore domain and activation gate
The structure of the truncated bacterial K+ channel KcsA, which is
essentially an isolated pore domain, defines the basic principles of ion
conduction and selectivity in all K+ channels (119, 120). KcsA shows how protein
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Figure 6: Structural homologs of SLO channels. For each SLO channel domain (voltage
sensor, pore and CTD), a structural homolog is shown (respectively: voltage sensor from
the paddle chimera Kv, PDB ID 2R9R, KcsA pore, PDB ID 1K4C, and MthK RCK
domains, PDB ID 1LNQ). For KcsA, K+ ions are shown in purple spheres, and the front
and back subunits are removed for clarity. For MthK, Ca2+ is shown as yellow spheres.
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residues provide a pathway allowing ions to cross the membrane: a central
aqueous cavity stabilizes hydrated ions in the low dielectric environment of the
lipid bilayer, and the selectivity filter close to the extracellular side acts as a
gatekeeper responsible for K+ selectivity. The precise geometry of the filter
provides a polar environment mimicking the specific coordination of K+ ions by
water molecules, explaining how K+ can move through at a rate close to their
diffusion limit in water and why other ions such as Na+, which prefer a different
coordination, are excluded (120, 121).
Since the selectivity filter and the inner helices (S6 in SLO) of the pore are
the only regions lining the ion pathway, they must contain the channel’s
activation gate that switches ion flow on or off. The crystal structure of the
ligand-bound MthK, a bacterial Ca2+-gated K+ channel, provides a striking
illustration of how the movement of the inner helices contributes to channel
gating (122, 123). In the Ca2+-bound, open conformation of the MthK structure,
the inner helices are bent outwards providing a physical access to the inner
cavity from the intracellular side (Figure 7) (123). In contrast, in KcsA the same
helices form a narrow (~4 Å) hydrophobic bundle at the intracellular entry,
forbidding the movement of K+. Subsequent structural characterization of other
K+- or related channels reinforced the concept that the movement of inner helices
is central to channel activation (124-131). In MthK, the open inner helices bend at
a Gly residue (“Gly hinge”) that is conserved throughout the K+ channel family
and is a major determinant of channel activation (123, 132).
How do these principles apply to SLO channels? All the relevant studies
have so far focused on SLO1. Functional experiments revealed that, in SLO1,
rearrangement of the inner helices occurs during the closed-to-open transition
(133, 134). Importantly, two consecutive Gly are present in SLO1 at the position
corresponding to the “Gly hinge” in MthK. Mutation of either Gly to Ala impairs

	
  

21

Figure 7: Closed and open pores in K+ channel structures. The pore regions of the
closed KcsA (PDB ID 1K4C) and the open MthK (PDB ID 1LNQ) are shown. In MthK,
the inner helices (blue) splay open at a conserved Gly residue (red).

	
  

22

SLO1 opening, and in the double Ala mutant the voltage required to open the
channel in 100 µM Ca2+ is shifted by ~ 130 mV to higher values (132). Thus, inner
helix flexibility is an important aspect of SLO1 gating. Whether the same applies
to SLO2 or SLO3 remains to be tested. Additionally, the precise conformational
changes occurring in SLO1’s inner helix during activation are still to be
characterized (21, 133-136).

1.3.3) Voltage sensors
In canonical voltage-gated channels, functional and structural studies
have revealed that voltage-sensing stems from the movement, in response to
voltage changes, of positively charged amino acids (“gating charges”) located in
the S4 transmembrane helix (1, 137-142). Gating charge movement manifests
itself in a measurable “gating current” prior to channel opening (143). Functional
experiments coupling mutagenesis and gating current measurement in the
archetypical Shaker voltage-gated K+ channel identified the implicated residues in
S4 (four Arg and one Lys), and established that each Shaker tetramer contains 1214 gating charges, or ~3.5 per individual voltage sensor. The crystal structures of
the bacterial KvAP and the eukaryotic Kv1.2 and Kv1.2/Kv2.1 “paddle chimera”
channels define the molecular architecture of the voltage sensor in classical
voltage-dependent K+ (Kv) channels, and show that voltage sensors (S1 to S4) are
essentially independent domains embedded in the lipid bilayer (124, 125, 141).
The linker between S4 and the pore’s outer helix, S5, provides the allosteric
connection that translates voltage sensor movement into pore opening (138).
The voltage dependence of SLO1 and SLO3 likely originates from the
same principles. Sequence analysis reveals that most of Shaker’s gating charge
residues are conserved in SLO1 or SLO3 (94, 144). However, there is a
discrepancy between this apparent conservation of number of charged residues
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in S4 and the actual number of gating charges: gating currents have been
measured in SLO1 (145), but quantitative measurements showed that SLO1
possess only 2-4 gating charges per tetramer (144, 145), compared to Shaker’s 1214 (146, 147). Mutagenesis studies in SLO1 further showed that, in S4, only the
last Arg (R213) carries a gating charge (144). Hence, the actual structure of the
voltage sensors of SLO1 (and probably SLO3) is surely pretty divergent from that
of canonical Kv channels. Another important difference is the presence in SLO1
and SLO3 of the additional transmembrane helix S0, which has been proposed to
directly interact with the core of the voltage sensor domains based on
mutagenesis and cross-linking experiments (148, 149).
Lastly, the voltage dependence of SLO2 remains largely unexplained since
its S4 segment does not show any obvious conservation of positively charged
residues, even though SLO2 currents are voltage-sensitive (90, 150).

1.3.4) CTD: tandem RCK domains and functional implications
The basic architecture of the large intracellular CTD is expected to be
conserved among the different SLO channels, based on sequence conservation
(151). An elegant proof that the CTD is the basic unit responsible for intracellular
activation, and that CTDs from different SLO channels are indeed similar in
structure, came from experiments using chimeras between SLO1 and SLO3. By
swapping CTDs between SLO1 and SLO3, Lingle and colleagues showed that the
CTD alone is responsible for the specific response to Ca2+ vs. pHi: a chimeric
channel with a SLO1 transmembrane domain (S0 to S6) and a SLO3 CTD
becomes alkalization-activated but Ca2+-insensitive, and vice versa (23).
It was first recognized by sequence analysis that the CTD is evolutionary
related to a class of protein domains ubiquitous in prokaryotic K+ channels and
K+ pumps: the RCK domains (for Regulating the Conductance of K+) (24, 151-
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154). The first snapshot of the RCK domain fold came from the crystal structure
of the RCK domain from the E. coli K+ channel (24), which also suggested that the
functional RCK unit is formed by a dimer of RCK domains interacting through a
large protein interface. A salt bridge can be seen in the structure, and is
conserved in the sequence corresponding to RCK1 in SLO channels as
demonstrated by mutant-cycle mutagenesis studies in SLO1 (24). This proved the
existence of at least one RCK domain in the CTD of SLO channels. In-depth
sequence analysis showed that another RCK domain (RCK2) could be found in
the SLO CTD, so that the CTD actually contains a tandem of RCK domains (151,
151).
Subsequently, the structure of the prokaryotic Ca2+-activated K+ channel
MthK offered the first picture of a full channel whose gating apparatus is formed
by RCK domains (122). The sequence of MthK encodes only one RCK domain,
but an alternative start site at the RCK N-terminus initiates the translation of a
second identical RCK domain that assembles with the first, pore-attached RCK in
the full channel, showing that dimerization is a trademark of RCK function (122)
(Figure 8a). Moreover, in the MthK tetramer, four RCK dimers are seen to
assemble in a “gating ring” at the intracellular surface of the membrane (122)
(Figure 8a). The structure suggested a simple hypothesis for RCK-mediated
gating in MthK: in response to Ca2+ binding, conformational changes at the RCK
level cause a dilation of the gating ring, which in turn pulls the pore’s inner
helices to open the channel (122). This mechanism was later confirmed by
crystallographic studies on an isolated MthK gating ring (without the pore
domain) in which the Ca2+ binding site was disabled by mutation, most likely
representing the “closed” conformation of the gating ring (155). Comparison of
this structure with the original Ca2+-bound, open gating ring shows that upon
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8a

gating ring

8b

Figure 8: MthK gating ring. 8a) Structure of the MthK tetrameric gating ring (PDB ID
1LNQ). The topology of one subunit in shown in inset: the MthK CTD is made by the
repeat of the same RCK domain. In all panels, RCK1 and RCK2 are color-coded blue and
red, respectively. 8b) Ca2+ causes the MthK gating ring to expand, leading to channel
opening. The gating rings are seen from the top, and the red spheres mark the very Nterminal CTD residues, linked to the channel pore. PDB ID: 2FY8 (closed), 1LNQ (open).
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Ca2+ binding the ring’s diameter expands from 66 to 74Å, driving channel
opening (122, 123, 155, 156) (Figure 8b).
The presence of a RCK tandem in SLO channels strongly suggests
similarities in function with MthK. In addition, the “gating ring expansion”
model predicts that the amino-acid linkers between the pore’s inner helices and
the RCK N-termini serve essentially as passive tethers transducing the
mechanical force of gating ring dilation into channel opening. Functional
experiments in SLO1 where the linker length was systematically modified
support this model, showing that increase or decrease in the length, respectively,
impairs or potentiates Ca2+-driven activation, and that this effect varies linearly
with length, the linker acting essentially as a spring (151, 157). Altogether, the
structure and mechanism of MthK provides a basic framework for
understanding the activation of SLO channels by intracellular signals.

1.3.5) Ca2+ activation in SLO1
What more is known about the functional mechanisms of SLO channel
activation by Ca2+, Na+ or pHi? In particular, where in the CTD is the ligand
binding site or sensor located? Here again, only SLO1 has been studied in detail.
The first insight into the location of the Ca2+ binding site(s) in the SLO1 CTD took
advantage of the different Ca2+ sensitivities of mouse and drosophila channels.
Swapping RCK2 between the two channels established that this domain is
responsible for the difference (158). More detailed mutagenesis analysis
narrowed down the RCK2 sequence critical for Ca2+ activation: a stretch rich in
Asp residues, absolutely conserved across species, named the “Ca2+ bowl” by the
authors (889QFLDQDDDDDPD900, numbering corresponding to the human
protein) (159). A systematic alanine scan of the whole Ca2+ bowl and flanking
regions revealed that mutating two of the Asp (D895 and D897) had the most
severe effect (160). Furthermore, radioactive assays in which 45Ca2+ binding can
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be detected on a RCK2 fragment containing the Ca2+ bowl (161, 162) showed that,
in the double mutant D895A-D897A,

45

Ca2+ signal is reduced by 80%, further

suggesting that the corresponding side chains might directly coordinate Ca2+
(160, 160). Another study involved chimeric SLO1/SLO3 channels (163).
Replacing the RCK2 domain of SLO1 by the corresponding SLO3 sequence
creates channels that are completely Ca2+-insensitive. Now, in this background,
introducing back a SLO1 region of 34 amino-acids encompassing the Ca2+ bowl
restores most of the Ca2+ sensitivity (163). Thus, the calcium bowl appears to be
the main Ca2+ binding site responsible for SLO1 activation.
However, the Ca2+ bowl is likely not the only Ca2+ binding site in SLO1.
Indeed, deleterious mutations in the Ca2+ bowl sequence abolish most, but not
all, of SLO1’s Ca2+ sensitivity (159). In particular, SLO1 channels in which the
Ca2+ bowl region (893QDDDDDPD900) is completely removed are still functional
and Ca2+-activated: raising [Ca2+] from 3 nM to 10 µM Ca2+ causes a -80 mV shift
in the midpoint of voltage activation (compared to -170 mV in wt channels) (164).
The precise location of the other Ca2+ binding site(s) is still unknown. Three
residues located in RCK1 have been implicated (D367, M513 and E535) (164-166).
Mutating either of these residues to Ala almost abolishes the high-affinity (<10
µM) response to Ca2+ in the background of a Ca2+-bowl-disabled SLO1 channel
(164-166). However, whether these amino acids directly coordinate Ca2+ or act
through an indirect effect is unresolved. In particular, direct biochemical
evidence for Ca2+ binding in RCK1 is missing.
Importantly, none of the proposed high-affinity Ca2+ binding sites appear
to match the binding sites seen in the MthK structure (122, 151). Hence, even
though MthK and SLO1 likely share similarities in how conformational changes
at the CTD level drive channel opening, the details of how the energy of Ca2+
binding is transduced into channel activation surely differ between the two
channels.
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1.4 – RESEARCH PROJECT
SLO channels: studying the structure to understand function

Overall, SLO channels are an important class of K+ channels involved in a
myriad of physiological processes ranging from muscle contraction to sperm
motility. Understanding the gating of these channels is key to understanding the
specific cellular functions controlled by their activity. The evolutionary link
between the SLO family and other channels of known molecular structure
provides a basic framework for understanding the gating mechanisms of SLO1,
SLO2 and SLO3. However, as we have seen, the unique features of SLO channels
(be it in terms of voltage- or intracellular activation) cannot be explained by
simply drawing parallels between SLO channels and their distant relatives (21,
118, 151, 167). To really understand how SLO channels operate at the molecular
level, a direct knowledge of the atomic structure of these proteins is needed.
Such knowledge would pave the way for functional studies specifically designed
to probe particular aspects of SLO channels’ operation.
The goal of my Ph.D. work is to study the atomic structure of SLO
channels, and to use this information to discover new aspects of how these
molecular machines perform their function in cells. To this end, I used two
experimental techniques: X-ray crystallography, which is a way to directly
investigate the atomic arrangements of any molecule (in particular proteins); and
electrophysiology, which allows the direct study of the function of ion channels
by measuring the electrical currents they mediate.
In addition to the fascinating challenge of understanding the chemical and
physical foundations of cellular functions (especially in the context of human
physiology), this work is also motivated by its potential contribution to the
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treatment of diseases. As we have seen, SLO channels (and in particular SLO1)
are attractive drug targets. Structural information can be instrumental in the
design and development of therapeutic molecules (168), as shown by the
example of HIV protease inhibitors used for the treatment of AIDS (169, 170).
Furthermore, the biochemical characterization and large-scale production effort
that preludes any crystallographic analysis can also lead to the development of
new tools for pharmacological studies.

The specific questions I decided to study relate to the distinctive, key
property of SLO channels: their activation by intracellular signals. Can we
understand how binding of an ion, or a change in pH, modulate these proteins to
promote channel opening? Since SLO1, SLO2 and SLO3 are closely related, do
they share the same principles of activation? For example, do Ca2+, Na+ and pHi
act on the same site(s) in the three homologs, or did evolution make use of
different opportunities within the same basic protein scaffold?
As we will see, structural studies of eukaryotic proteins as complex as
SLO channels constitute an important technical challenge, and I was very
fortunate to work on this project alongside two very talented scientists: first and
foremost Peng Yuan, a post-doc, whose excellent expertise and mentorship was
central to the work I will present; and Yichun Hsiung, a research assistant, whose
skillfulness was essential for dealing with the large amount of cell culture that
this project required. All the data I will describe in this dissertation are
fundamentally the result of our team effort.
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In my thesis, I will describe our effort to characterize structurally SLO
channels, as well as to use this structural knowledge to probe fundamental
aspects of how SLO channels function, in particular how channel activation is
mediated by ligand binding or pH change at the intracellular level. In the next
chapter, I will present our endeavors to crystallize entire SLO channels, and my
work on developing methods to express large quantities of full-length SLO1
channels in eukaryotic heterologous systems, and to purify these proteins while
making sure they retain full functionality. Using a specific toxin-binding assay as
a probe, I will show how expression and purification of functional SLO1 is highly
dependent on the choice of expression system, but can be achieved in insect or
mammalian cell lines.
In the subsequent chapters, I will describe our results on determining the
atomic structures of isolated CTDs from SLO1 and SLO3. In Chapter 3, we will
look at two structures of the human and zebrafish SLO1 CTDs, solved by Peng in
the presence of Ca2+. We will see how, together with studies from other
laboratories, these structures illustrate how the binding of Ca2+ in the SLO1 CTD
changes the conformation of the protein to open the channel pore. In Chapter 4, I
will describe the structure I solved of the human SLO3 CTD and present
electrophysiological results that explain the molecular mechanisms of pH
sensing in mammalian SLO3 channels. In the final discussion, I will compare
these different structures together and examine how they define new unique
properties of SLO channels regulation by intracellular signals, and discuss the
evolutionary relationship of RCK-mediated ion channel gating.
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CHAPTER TWO:

EXPRESSION OF FULL-LENGTH SLO CHANNELS IN
EUKARYOTIC HETEROLOGOUS SYSTEMS
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As we have seen, direct knowledge of the atomic structure of SLO
channels is required to understand the precise molecular events controlling
gating in these proteins. X-ray crystallography is the primary experimental
method to obtain structural information of proteins at the atomic scale. An X-ray
crystallography experiment involves two major steps: first, one must find
suitable conditions to obtain three-dimensional crystals of the protein of interest;
then, the atomic details of these crystals are probed under an X-ray beam, and
the resulting data are processed into an atomic structure of the proteins forming
the crystal. The major bottleneck in X-ray crystallography is to obtain protein
crystals. Crystallization of proteins follows the same principles of crystallization
as for any molecule or mineral. To crystallize, a molecule in solution needs to be
brought above its solubility limit: the solution then becomes supersaturated and
metastable, leading to precipitation or, if the right conditions are met,
crystallization. The most common way to reach the solubility limit is to increase
the concentration of the molecule.
Thus, crystallizing proteins typically requires high concentrations of
starting material. In practice, this means that large quantities of proteins need to
be obtained. To this end, two options are available. The first one is to make use of
a natural tissue where the protein is enriched. The other option is to force the
expression of the protein in a heterologous system. Heterologous expression is
often the method of choice in present-day crystallography because it allows one
to work with proteins for which no practical natural source is available (as is the
case for SLO channels) and it allows tailoring the protein of interest to facilitate
its subsequent purification and crystallization.
Crystallography of membrane proteins presents unique challenges. First,
heterologous over-expression of membrane proteins is particularly difficult, due
to the complexity of membrane protein folding and the limited area of the cell
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membrane (171, 172). Second, current biochemical techniques require that
membrane proteins be extracted from the native lipid bilayer in a water-soluble
form, typically by solubilizing the hydrophobic transmembrane core in a
detergent micelle (173). Eukaryotic membrane proteins such as SLO channels are
even more difficult to work with, and the first eukaryotic membrane protein
structure obtained using heterologous expression was solved only recently, in
2005 (1).
The first goal of my Ph.D. work was to develop methods for the largescale production and purification of SLO channels, the necessary first step of any
crystallographic undertaking. In this chapter, I describe my efforts to express
functional SLO1 channels in three different systems commonly used for
eukaryotic protein expression (172): Pichia pastoris yeast, Sf9 insect cells and
human HEK cell line. As a first approach to probe the functionality of the
purified proteins, I developed techniques to screen whether purified SLO1
channels obtained from these different expression systems are able to bind a
specific toxin molecule that recognizes only properly folded SLO1 tetramers. I
will show that SLO1 channels expressed from HEK or Sf9 cells, but not from
Pichia yeast, are competent to bind the toxin and are indeed fully functional.
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2.1 – HETEROLOGOUS EXPRESSION OF SLO CHANNELS

2.1.1) Eukaryotic expression systems
I tested three eukaryotic systems for the heterologous over-expression of
SLO channels: the yeast Pichia pastoris, Sf9 insect cells and HEK human cell line
(172). Each system has its own specificities. Yeast can be grown in large
quantities using fairly inexpensive media, and Pichia cells in particular can reach
very high density compatible with fermentor culture (up to >100 g dry weight of
cells per liter of culture) (174). Yeast cells can carry out most, but not all, posttranslational modifications common to animal cells. Pichia is capable of
producing membrane proteins at high level. However, the lipid composition of
the Pichia membrane is quite different from that of a typical animal cell (for
example, yeast lack cholesterol). The first eukaryotic membrane protein structure
obtained using heterologous expression (the mammalian Kv1.2 potassium
channel) made use of the Pichia system (125). On the other hand, Sf9 or HEK cells
are bona fide animal cells that can be used for protein over-expression, but require
expensive cell culture media (172). HEK cells offer the most native environment
for the expression of mammalian membrane proteins, but these epithelial cells
are best grown attached on a surface, which limits large-scale production efforts
in practice. Sf9 insect cells can be conveniently grown in shaker flasks, and are
often the system of choice for eukaryotic protein expression (172).

2.1.2) Screening of SLO candidates using FSEC
I proceeded to screen the SLO family for candidates amenable for largescale production and purification. Typically, a good membrane protein candidate
for crystallization must fulfill three criteria: 1) have a sufficiently high yield of
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expression in the system of choice, 2) be stable, i.e. not prone to rapid
degradation upon purification and 3) be homogeneous, i.e. give rise to a
monodisperse species upon extraction from the lipid membrane by detergent
solubilization (175). FSEC (Fluorescent Size Exclusion Chromatography) is a
powerful method to screen for such candidates (175). In an FSEC experiment, the
protein of interest is fused to a GFP (Green Fluorescent Protein) molecule and the
biochemical behavior of the protein-GFP construct is followed by fluorometry
within the whole cell lysate, so that only small amounts of material are needed
and no purification is required. After cell lysis and detergent extraction, the
protein-GFP fusion is loaded on a gel filtration column that separates molecules
according to their size (size exclusion chromatography). A protein that is stable
and homogeneous will typically elute as a single, sharp peak on FSEC (175).
In an initial screen, I tested 9 different SLO1, SLO2 or SLO3 channels from
different species for expression in Pichia, Sf9 or HEK, the rationale being that
differences in protein sequence between species can have a big impact on the
ability of a protein to crystallize. These candidates represented all SLO channels
that had been cloned at the time (y. 2006), except for mammalian SLO1 channels,
which share extremely high amino-acid sequence identity (for example,
sequences from mouse and human SLO1 are 96% identical): for this clade, the
human SLO1 was chosen as a representative candidate. This initial screen
identified three promising candidates: SLO1 channels from human and the sea
slug Aplysia californica, and the rat SLO2.2. Representative FSEC profiles for these
three channels, expressed in HEK cells, are shown in Figure 9a. Expression in Sf9
or Pichia gave identical results (data not shown). A representative candidate that
did not pass the FSEC test (Caenorhabditis elegans SLO1) is shown in Figure 9b. A
close inspection of the data in Figure 9a reveals interesting differences in the
biochemical behavior of the three promising candidates: Aplysia SLO1 (AcSLO1)
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9a

Figure 9: FSEC screening in HEK cells. SLO

9b

channels were expressed in HEK cells as Cterminal GFP fusions, and the crude DDMsolubilized cell lysate was loaded on a Superose 6
gel filtration column, monitoring GFP fluorescence.
All traces are at the same scale. 9a) Best candidates.
The hSLO1 profile shows signs of non-specific
aggregation: a “shoulder” left of the main peak (#).
9b) Example of a bad candidate.

	
  

37

and rat SLO2.2 elute as single, monodisperse peaks, whereas the human SLO1
(hSLO1) gel filtration profile shows a high-molecular weight “shoulder” on the
left of the main peak, sign that the solubilized hSLO1 channel has a tendency to
aggregate. In terms of expression level, the yield for rat SLO2.2 is half compared
to that of AcSLO1.
Based on these initial results, I decided to focus on the two SLO1
candidates (AcSLO1 and hSLO1). AcSLO1 appeared to be the most promising
target, and the hSLO1 FSEC profile was encouraging enough to pursue,
considering that the structure of a human protein would have the biggest impact
on our understanding of human physiology and on new therapeutic possibilities.

2.1.3) Large-scale production and purification of AcSLO1 and hSLO1 channels
Large-scale production and purification of Aplysia AcSLO1 and human
hSLO1 were carried out using the Pichia and Sf9 systems. The purification was
done in three steps: 1) Pichia and Sf9 cells expressing AcSLO1 or hSLO1 were
lysed either mechanically (Pichia) or by sonication (Sf9) and membrane proteins
were extracted using n-dodecyl-β-D-maltoside (DDM) or n-decyl-β-D-maltoside
(DM) detergents; 2) the solubilized SLO1 channels were isolated from the crude
cell lysate by affinity chromatography; and 3) the channels were further purified
in a final gel filtration step. To facilitate affinity purification, I engineered an
affinity tag within the protein constructs. Initial attempts using a C-terminal
poly-His tag gave samples of low purity because of the relatively low expression
yield of hSLO1 or AcSLO1 in Pichia and Sf9: in this case the non-specific binding
of background contaminants to the affinity resin was too high. High purity was
achieved using a C-terminal 1D4 tag (TETSQVAPA), for which very specific
monoclonal antibodies are available. Some of the constructs I used also contained
a C-terminal GFP between the SLO1 sequence and the affinity tag, so that the
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channel construct can be easily followed by fluorometry at different steps during
purification. In order to remove the C-terminal 1D4 tag or GFP-1D4 tag prior to
crystallization, a protease cleavage site was added to the construct following the
SLO1 sequence. Two different cleavage sites were compared: a thrombin site and
a site recognized by the PreScission protease. Only PreScission showed specific
cleavage restricted to the engineered site, whereas thrombin treatment led to
additional non-specific proteolysis (data not shown). Schematics of the final
optimized expression constructs, obtained by fusing a PreScission site-1D4 tag or
a PreScission site-GFP-1D4 tag to the SLO1 C-terminus, are shown in Figure 10a.
By growing large cultures of Pichia or Sf9 cells, AcSLO1 and hSLO1
channels could be purified in milligram quantities (final protein yield per liter of
culture for either AcSLO1 or hSLO1: ~0.3 mg in Pichia; ~0.2 mg in Sf9). Gel
filtration profiles from the final purification step are shown in Figure 10b and 10c
(DDM was used as detergent). Three important characteristics can be seen in
these profiles. First, the gel filtration behavior of channels obtained from Pichia or
Sf9 cultures is essentially identical (compare Figures 10b and 10c). Second, the
elution volume of the main peak is consistent with purified channels being in a
tetrameric form. This was confirmed by chemical crosslinking experiments (see
Figure 10d showing the example of hSLO1 purified from Pichia, but the same
was observed with proteins purified from Sf9). Third, both AcSLO1 and hSLO1
exhibit signs of non-specific aggregation, which manifests itself as a “shoulder”
on the left of the main tetramer peak. When the tetramer peak is isolated,
concentrated and re-loaded on the gel filtration column, the channel further
aggregates, with hSLO1 behaving worse than AcSLO1 in this respect (Figure
10b). Over time, the isolated AcSLO1 tetramer peak will aggregate as well and
display a visible “shoulder” on gel filtration (data not shown).
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Overall, this large-scale purification effort seemed promising: AcSLO1 and
hSLO1 could be purified in quantities compatible with crystallization efforts, and
the channels were purified in their native oligomeric state. Before starting
intensive crystallization efforts, I decided to probe whether the purified channels
were also still fully functional.
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10a

10d

10b

10c

Figure 10: Expression and purification of SLO1 channels. 10a) Constructs used for
large-scale protein expression: C-terminal fusions containing PreScission site-1D4 tag or
PreScission site-GFP-1D4 tag (see text). PreScission protease is used to remove the added
C-terminal sequence during purification (red). 10b) Gel filtration profiles of AcSLO1 and
hSLO1 purified from Pichia, solubilized in DDM (Superose 6 column). Peaks
corresponding to SLO1 tetramers (asterisks) were isolated, concentrated and re-loaded
on the column (“re-run”). 10c) Same as in 10b) showing AcSLO1 and hSLO1 purified
from Sf9 expression. Peaks eluting at 17-20 mL mostly contain GFP. 10d) SDS-PAGE
showing chemical crosslinking of the isolated hSLO1 tetramer peak from Pichia
expression. Increasing concentrations of disuccinimidyl glutarate were used for
crosslinking. The SDS-PAGE was stained with Coomasie.
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2.2 – FUNCTIONAL STUDIES OF PURIFIED SLO1 CHANNELS

2.2.1) Toxin binding as a probe of SLO1 functional state
The absolute test to probe whether a purified ion channel retains its full
functional state is to reconstitute the solubilized channel into a lipid bilayer from
which ion channel function can be directly assessed by electrophysiology (176,
177). However, this method is time- and protein-consuming. Instead, I decided to
first study the ability of purified AcSLO1 and hSLO1 to bind toxins recognizing
specifically the native state of the channels. Natural peptides found in the venom
of scorpions have been shown to act as high-affinity blockers of K+ channels
(178). These “pore-blocker” toxins occlude ion conduction in cells by binding to
the channel’s extracellular mouth, at the interface between the four subunits of
the pore (Figure 11) (178, 179). Toxins can be extremely specific for a particular
kind of K+ channel, and toxin binding is a powerful tool to assess whether a
given channel retains its native state upon purification (180). Several toxins from
the charybdotoxin (ChTx) family, including ChTx itself, target SLO channels
(178). In particular iberiotoxin (IbTx), isolated from the venom of the Indian red
scorpion Buthus tamulus by the team of Maria Garcia at Merck Research
Laboratories, is a specific blocker of SLO1 (181). I therefore performed IbTxbinding assays to study the biochemical properties of AcSLO1 and hSLO1
expressed in heterologous systems.

2.2.2) 125I-IbTx binding assays on DDM-solubilized hSLO1
Maria Garcia and her colleagues have extensively studied binding of
ChTx and IbTx (the two toxins have nearly identical properties) to membraneembedded as well as solubilized hSLO1 (182, 183). Their standard protocol
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Figure 11: Pore-blocker toxins.
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Figure 12: Labeling of IbTx-D19C. 12a)
Position of the introduced Cys (shown as
spheres) in the toxin molecule. 12b) HPLC
profile of the last purification step from E.
coli expression (see Material and Methods).
The main peak corresponds to pure IbTxD19C (asterisk). 12c) HEK cells expressing
GFP-tagged hSLO1 (green) were incubated
with

90

nM

IbTx-D19C

fluorescently

labeled with tetramethylrhodamine (TMR,
red). A competition assay in the presence
of large excess of unlabeled IbTx shows
that the binding is specific.
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makes use of toxin derivatives radiolabeled with

125

I by iodination on Tyr

residues. In a binding assay, solubilized hSLO1 or membrane preparations
containing hSLO1 are incubated with

125

I-ChTx or

125

I-IbTx, and the toxin-

receptor complex is recovered by filtration on treated glass filters, which are then
counted for 125I γ radiation (1).
Electrophysiology experiments done in extracellular salt conditions close
to physiological levels (90 mM Na+ and 2.5 mM K+) show that

125

I-IbTx blocks

hSLO1 with a KD of ~1.5 nM, almost identical to native IbTx (KD ~1 nM) (183).
However, binding affinity can be increased by removing all external K+ and
using an extracellular buffer of very low ionic strength. Using a buffer containing
only 10 mM NaCl and 20 mM TRIS-HCl pH 7.4 (+ 0.1% BSA to limit non-specific
binding), 125I-IbTx binds in vitro to membranes containing hSLO1 with a KD of ~5
pM (183). These specific conditions (0 K+ and low ionic strength) have been used
in all toxin binding studies published so far, because the very high affinity allows
using minimal amounts of radiolabeled toxin.
Toxin binding on solubilized hSLO1 has been studied using the same
conditions. The Garcia lab showed that picomolar

125

I-ChTx binding on

solubilized hSLO1 could be achieved using digitonin as a detergent, but not
DDM (182). Digitonin is an unusual detergent that interacts with membrane
cholesterol and solubilizes membrane proteins along with an annulus of
phospholipids (184). Digitonin is very expensive, toxic and difficult to obtain in a
pure and homogeneous form, all of which undermine its practical use for
membrane protein crystallization (185, 186). On the other hand, mild glycosydic
detergents such as DDM or DM are well-suited and very commonly used for
crystallization efforts (186).
With the help of Maria Garcia and her colleagues, I attempted to
reproduce their findings using DDM-solubilized hSLO1 obtained from Pichia or
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Sf9 expression. Indeed, under the standard 0 K+ and low ionic strength
conditions, we could not detect any picomolar 125I-IbTx binding to these samples
(data not shown). Does this mean that, in DDM micelles, solubilized hSLO1 is
denatured in a non-native, toxin-insensitive form? This would be a significant
drawback for our crystallographic undertaking. However, I reasoned that
another phenomenon could explain these results. It is known that, at least in
detergent micelles, the selectivity filter of K+ channels changes its conformation
depending on K+ concentration (120). At low [K+] (~2 mM), the crystal structure
of KcsA shows that the selectivity filter adopts a “collapsed” conformation
drastically affecting the geometry of the K+ binding sites (120). Interestingly, it is
known that pore-blocker toxins such as ChTx or IbTx bind in the immediate
vicinity of the filter’s K+ sites (178, 187). Hence, it is possible that, in the standard
125

I-toxin binding protocol using non-physiological K+-free conditions, the

conformation of hSLO1 is affected in a way that prevents toxin binding (most
probably due to a conformational change in the channel’s selectivity filter). To
test this hypothesis, I needed to perform toxin-binding studies in the presence of
K+ .

2.2.3) Development of a K+-compatible IbTx binding assay
In practice,

125

I-IbTx cannot be used to study toxin-channel interactions in

the presence of K+. This is because the synthesis of large quantities of radioactive
125

I-IbTx is quite inconvenient, so that its usage is limited to conditions where

toxin binding has picomolar affinity (i.e. 0 K+, low salt conditions), thus allowing
the use of very low quantities of material. I thus decided to develop a new IbTx
binding assay, which would be compatible with K+-containing buffers.
Toxins from the ChTx family can be recombinantly expressed in bacteria,
and introducing a Cys residue at position 19 (on the toxin’s upper surface) allows
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for specific labeling of the toxins without compromising their binding
capabilities (188, 189) (Figure 12a). Using protocols originally described for ChTx
(188), I could produce and purify the Cys mutant IbTx-D19C expressed in E. coli
(see Materials and Methods section). An HPLC profile of the final purification
step is shown in Figure 12b. IbTx-D19C can be labeled on the introduced cysteine
and the labeled toxin binds hSLO1 with high affinity. An example is shown on
Figure 12c: IbTx-D19C labeled with the red fluorophore tetramethylrhodamine
(TMR, using a Cys-reactive maleimide conjugate) specifically binds HEK cells
expressing hSLO1 (toxin concentration: 90 nM).
To study IbTx binding on solubilized hSLO1, I first covalently linked
IbTx-D19C onto a Cys-reactive iodoacetyl agarose resin. The IbTx-coated resin
could then be used to pull-down solubilized hSLO1, and test the influence of [K+]
on the channel-toxin interaction. The results of such pull-down experiments are
shown in Figure 13a. In these experiments, hSLO1-GFP was solubilized from
HEK cells using either digitonin or DDM. The crude cell extract was then
incubated with IbTx resin, and hSLO1 binding to the resin was revealed by SDSPAGE, looking at GFP fluorescence. Figures 13a and 13b shows the requirement
of K+ for toxin binding on DDM-solubilized hSLO1; on the contrary, when
digitonin is used, binding occurs independently of K+ concentration.
Interestingly, for IbTx binding in DDM, K+ must be present during solubilization
itself: adding K+ to hSLO1 solubilized in a K+-free buffer does not rescue binding
(Figure 13b). In the case of AcSLO1, the wild-type protein does not bind IbTx due
to a sequence variation at the toxin receptor site (190). However, I could confer
IbTx binding to AcSLO1 by introducing, by mutagenesis, the hSLO1 sequence
corresponding to the expected receptor site (190) (a total of 7 mutations, see
Figure 13c). This mutant AcSLO1 (which I will from now on refer to as AcSLO1T,
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13a

13b

13d

13c

Figure 13: SLO1 pull-down on IbTx resin. 13a) IbTx-coated agarose resin binding to
hSLO1-GFP solubilized in either digitonin or DDM. SDS-PAGE revealed by GFP
fluorometry are shown. Each panel shows three lanes: total solubilized hSLO1 (“total”);
hSLO1 bound to IbTx-coated agarose resin (“IbTx”); non-specific binding to agarose
resin not conjugated to IbTx (“mock” beads). Both hSLO1 solubilization and resin
binding are carried out in buffer containing either 0 K+ or 30 mM K+. 13b) Densitometry
quantification of experiments as in 13a). hSLO1 was solubilized in either digitonin or
DDM. Specified K+ concentrations are used during both solubilization and resin binding
(0 or 30 mM, “throughout”), or during resin binding only (30 mM, solubilization carried
out in 0 K+). Binding is normalized to total solubilized material. 13c) Sequence alignment
showing the mutations introduced in AcSLO1T to confer toxin sensitivity (cyan). The
selectivity filter sequence is shown in yellow. Numbers correspond to hSLO1 sequence
numbering. 13d) Same as 13b) showing normalized binding of AcSLO1wt and IbTxsensitive AcSLO1T. Channels were solubilized in DDM in the presence of 30 mM K+.
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for toxin) binds to IbTx resin when solubilized in DDM in the presence of K+
(Figure 13d).
Overall, the IbTx-resin pull-down experiments proved that SLO1 channels
can indeed be solubilized in DDM and still bind IbTx, provided that high enough
[K+] is present. These results gave a qualitative analysis of IbTx binding on
solubilized SLO1.

2.2.4) Quantitative IbTx binding on purified SLO1 from Pichia and Sf9 expression

To truly assess the functional state of purified SLO1 channels obtained
from Pichia or Sf9 large-scale expression, a quantitative assay was needed. In
essence, I wanted to answer the following question: what proportion of channels
can be purified in a toxin-binding competent, presumably native state? To this
end, I turned to radioligand binding assays.
I labeled IbTx-D19C with 14C-N-ethylmaleimide, a commercially available
Cys-reactive radioactive probe, following protocols already described for similar
experiments with ChTx (188). 14C labeling was essentially complete: the specific
activity I measured for the labeled 14C-IbTx using spectroscopic absorbance at 280
nm (A280) to calculate toxin concentration was in excellent agreement with the
expected value (measured: 31.5 ±0.3 Ci/mol, expected: 33.2 Ci/mol).
Importantly, I could easily produce large quantities of 14C-IbTx, compatible with
binding assays for which binding interaction is in the nM range.
With this tool in hand, I performed quantitative 14C-IbTx binding assays
on purified SLO1 channels from Pichia and Sf9 expression. I used a protocol that
was essentially identical to the

125

I-IbTx experiments I described previously: 14C-

IbTx was incubated with solubilized channels and the toxin-channel complex
was recovered on treated glass filters, extensively washed in ice-cold buffer and
14
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Methods section). hSLO1 and AcSLO1 channels purified from Sf9 showed robust
IbTx binding using this assay: a representative example is shown in Figure 14,
using toxin-sensitive AcSLO1T solubilized in DM. By using A280 to calculate the
concentration of purified SLO1 used to set up these assays, I could quantify that
at least ~60% of the expected receptors bound to 14C-IbTx in DM micelles. It is
hard to know if this number means that a fraction of purified channels is in a
toxin-insensitive state, or if it results from practical limitations of incomplete
protein recovery on the glass filters and/or errors in estimating protein
concentration (I used a theoretical calculation for the extinction coefficient ε280).
For SLO1 channels expressed in Pichia, the results were drastically
different: when the same experiments were performed, no binding could be
detected (data not shown). This was further confirmed using the qualitative pulldown assays on IbTx-coated resin. Whereas SLO1 expressed in Sf9 showed
robust binding to the resin, no binding could be detected with Pichia-expressed
channels (data not shown).

2.2.5) Functional reconstitution of SLO1 channels expressed in Sf9
The IbTx-binding studies suggested that DM- or DDM-solubilized SLO1
channels produced in Sf9, but not Pichia, could be purified in a native state. To
further confirm the functional state of the purified proteins, I reconstituted these
channels in lipid vesicles (POPE:POPG 3:1) and studied their function by
electrophysiology in an artificial lipid bilayer system. SLO1 channels from Sf9
were indeed fully functional since channel activity could be recorded (Figure 15).
In the case of Pichia expression, I could never see any electrophysiological
activity despite repeated reconstitution attempts (data not shown). Hence, it
seems that only Sf9, and not Pichia, is suitable for the large-scale heterologous
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Figure 14: 14C-IbTx binding to purified
AcSLO1T in DM micelles (from Sf9
expression). Toxin-channel complexes
were

recovered

by

filtration.

The

experiment was set up with 100 nM
channels. Each point is the mean of two
measurements (shown ± range). Data
were fitted to a binding isotherm.
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Figure 15: Electrophysiological recordings of reconstituted AcSLO1T from Sf9
expression. Recordings were made in symmetrical 150 mM KCl, holding at + 150 mV.
Channel activity was blocked by adding 200 nM IbTx to the external side.
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expression of functional SLO1 channels (HEK cells are also an option, since SLO1
from HEK expression binds IbTx in pull-down assays, as I presented in Figure
13). This result was surprising and interesting, since Pichia is routinely used in
our laboratory for the expression of eukaryotic K+ channels. I will discuss this
finding in more details in the discussion section at the end of this chapter.
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2.3 – PROGRESS TOWARDS A SLO CHANNEL STRUCTURE

Altogether, the functional studies on purified SLO1 showed that Sf9 insect
cells are a suitable heterologous expression system for crystallographic studies of
SLO channels. This works paves the way for the study of SLO channel atomic
structure by X-ray crystallography. However, despite our endeavor, we have
been so far unable to obtain crystals of AcSLO1 or hSLO1. As I will present in the
next chapters, our immediate effort later switched to crystallographic studies on
the SLO intracellular CTD, which led to important new insights on SLO channel
functional and gating mechanisms. The crystal structure of a full SLO channel
remains a major goal of research in our laboratory. In this section, I would like to
quickly summarize results I obtained while trying to crystallize AcSLO1 or
hSLO1, which I believe are significant for any future crystallization studies of
SLO1 channels.

2.3.1) SLO1 proteolysis and truncation studies
Purified SLO1 channels are quite sensitive to proteolysis. Even in a typical
purification procedure, where special care is taken to limit proteolysis to a
minimum (inclusion of a very diverse protease inhibitor cocktail during cell lysis,
keeping the temperature at 4°C or below during all stages of purification),
proteolytic cleavage can be seen (Figure 16a). Treatment with specific proteases
further reveals this sensitivity. The example of limited proteolysis with
chymotrypsin is shown in Figure 16a: no robust, proteolysis-resistant protein
core can be seen on SDS-PAGE (the same applies to many other common
proteases: trypsin, elastase, subtilisin, Glu-C, Lys-C and Arg-C).
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Sensitivity to proteolysis is often associated with the presence of poorly
structured regions in a protein. SLO channels are very big proteins (~1100
residues per monomer) and contain many loops between secondary structure
elements that are expected to be surface-exposed and disordered (151). Such
poorly structured regions are typically a problem for crystallization because they
create structural heterogeneity at the protein surface. In limited proteolysis
studies, I could identify the long linker (~100 amino acids, see Figure 16b)
between RCK1 and RCK2 as a major proteolytic site (data not shown).
Interestingly, it is known that most of this linker can be removed without
affecting channel function by co-expressing in trans a construct containing the
transmembrane and RCK1 domains together with a construct containing RCK2
on its own (a simple deletion within a single construct does not work, surely
because the linker bridges together two very distant parts within the protein)
(151, 158). When I tested such co-expression with hSLO1 in HEK cells, the results
looked fairly promising: the different domains assemble in the expected
complete tetramer in a peak sharper than the wild-type protein itself (Figure
16c).
Additionally, I could show that the unstructured N- and C-termini as well
as a long (~40 amino acids) unstructured loop in the middle of RCK2 could be
removed without affecting the biochemical behavior of purified SLO1 (data not
shown). Previous studies have shown that none of these parts are essential for
function (151). Altogether, truncations of these parts, as well as truncation of the
RCK1-RCK2 linker in a co-expression strategy, could facilitate crystallization by
limiting structural heterogeneity.
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16a

16b)

16c

Figure 16: SLO1 proteolysis and RCK1-RCK2 linker deletion. 16a) AcSLO1 limited
proteolysis. SDS-PAGE showing purified AcSLO1 from Sf9 expression. Adding
increasing concentrations of chymotrypsin does not reveal an obvious stable, protease
resistant core. 16b) The long RCK1-RCK2 linker is a major proteolytic site. 16c) The
RCK1-RCK2 linker can be removed using a strategy where two moieties of the SLO1
molecule are expressed in trans (insets). Shown are FSEC profiles from hSLO1
expression in HEK cells (Superose 6 column). The two traces are at the same scale. Upon
linker removal, the whole hSLO1 channel still assembles as a proper tetramer.
Interestingly, the hSLO1 tetramer elutes as a peak sharper that wild-type. The species
eluting after 16 mL contain excess RCK2-GFP and free GFP.
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2.3.2) Effect of divalent cations on SLO1 gel filtration behavior
The addition of ligand can often stabilize a purified protein. Ca2+ of
course, but also Mg2+, activate SLO1 (21). Adding high concentrations of Ca2+ and
Mg2+ improved the behavior of purified SLO1 on gel filtration (Figure 17). I have
not studied this effect in a systematic way, but the presence of divalent cations
could be important for the stability of purified SLO1.

2.3.3) Choice of detergent for purification
The right choice of detergent, specific to each membrane protein, is often
crucial for crystallization (186). I compared the gel filtration behavior of purified
SLO1 channels in a large array of different detergents. Alkyl and Cymal
maltosides, as well as polyoxyethylene glycol detergents gave similar gel
filtration profiles, whereas glucosides (typically more dispersive) made the
protein unstable (data not shown). Interestingly, the use of zwitteronic
detergents such as amine-oxides or zwittergents improved gel filtration
behavior. In particular, the profiles in LDAO or Zwittergent 3-12 seemed quite
promising (Figure 20). Importantly, the elution volumes in LDAO or Zwittergent
3-12 suggested that SLO1 channels were still tetrameric in these detergents.
However, functional studies need to be performed to insure that the use of these
detergents preserves the channels in a functional state.
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Figure 17: Effect of Ca2+ and Mg2+ on purified SLO1 gel filtration profile. Shown are
gel filtration profiles (Superose 6 column) of purified AcSLO1 from Sf9 expression. The
two samples come from the same protein preparation. Addition of high concentration of
divalents cations (Ca2+ and Mg2+) improves the gel filtration behavior of AcSLO1: the
elution peak is sharper and more monodisperse.

Figure 18: Comparing detergents for SLO1 solubilization. Shown are gel filtration
profiles of purified AcSLO1 solubilized in DM, Zwittergent 3-12 or LDAO. All samples
come from the same protein preparation. Zwitterionic detergents (Zw. 3-12, LDAO)
improve the gel filtration behavior of AcSLO1.
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2.4 – DISCUSSION
Expression of SLO channels in heterologous systems and purification

In summary, I have explored the heterologous expression of SLO channels
in three different systems: HEK, Pichia and Sf9 cells. Initial screens revealed that
human and Aplysia californica SLO1 channels are promising targets for
crystallization efforts. Large-scale expression in Pichia and Sf9 led to the
purification of milligram quantities of tetrameric hSLO1 or AcSLO1 solubilized
in DM or DDM micelles. However, quantitative toxin binding studies revealed a
major difference between these two expression systems. Purified SLO1 from Sf9
expression bound IbTx, and electrophysiological studies on reconstituted
proteins confirmed that the channels are indeed fully functional. On the other
hand, SLO1 channels purified from Pichia expression did not bind IbTx and
showed no functional activity when reconstituted in lipid membranes. What
could explain this discrepancy?
I can think of three possibilities that would explain the absence of toxin
binding and functional activity of SLO1 purified from Pichia: 1) Pichia yeast cells
are not able to process and fold SLO1 channels, which only exist in the Metazoa
kingdom. However, the fact that SLO1 from Pichia expression have their
expected oligomeric form would suggest that this possibility is unlikely.
Furthermore, the gel filtration behavior of proteins expressed in Pichia and Sf9 is
identical; 2) SLO1 from Pichia expression actually co-purifies with a yeast-specific
contaminant that impedes toxin binding and functional activity. In theory, a
small molecule binding strongly to the channel’s extracellular mouth could
physically prevent toxin binding and occlude ion flow. I have not studied
whether any such species is present in the SLO1 purified samples, but this could
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be done, for example by using mass spectrometry. This second explanation
seems quite improbable, but cannot be entirely ruled out; 3) SLO1 function as
well as toxin binding require the presence of a specific cofactor, for example from
the cell membrane, that is lacking is yeast cells. This third possibility is by far the
most reasonable.
The membrane composition of yeast cells is quite different from that of
animal cells. For example, yeast completely lack cholesterol, which is an essential
component of animal membranes. Instead, the yeast membrane is rich in another
sterol, ergosterol (191). Studies of mammalian G-protein coupled receptors
(GPCR) have shown that ergosterol and cholesterol, even though very similar in
structure, do not have the same functional properties. In the case of the human µopioid GPCR, ergosterol cannot be substituted for cholesterol to promote protein
function, and µ-opioid receptors are expressed in yeast in an inactive form,
which does not bind classical agonists (192). Interestingly, adding cholesterol to
the yeast membrane restores agonist binding and function (192). This example
illustrates how the functional properties of membrane proteins expressed in
yeast can be impaired by the singular composition of the yeast lipid membrane.
No specific lipid requirement for SLO1 function has been described, but
cholesterol itself could be a candidate. It is indeed interesting that digitonin,
which is known to directly interact with cholesterol (and presumably solubilizes
membrane proteins along with a small cholesterol-containing patch of
membrane), has a very unique effect on SLO1 solubilization. Overall, probing
whether SLO1 channels interact with specific components of the cell membrane
is an important physiological question. The methods I developed, which for the
first time allow large-scale purification of functional SLO1 channels, could open
the way for such studies by providing an experimental system in which the
precise molecular composition can be controlled.
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CHAPTER THREE:

CRYSTAL STRUCTURES OF THE CA2+-BOUND SLO1
CYTOPLASMIC DOMAIN AND MECHANISM OF CA2+ GATING
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While still working on crystallizing a full-length SLO channel, we decided
to also explore another strategy. As I described in Chapter 1, the gating of SLO
channels by intracellular signals (Ca2+ for SLO1, Na+ for SLO2, pH for SLO3) is at
the core of their physiological functions. Since intracellular activation of SLO
channels is controlled by their large cytoplasmic domain (CTD) (23), we decided,
together with my close collaborator and mentor Peng, to study the atomic
structure of isolated CTDs from different SLO channels using X-ray
crystallography. We reasoned that this structural information could teach us a lot
about the molecular basis of SLO channel gating. In particular, we wanted to
specifically address two questions: What kind of conformational change occurs
in the CTD upon ligand binding or pH change in order to promote channel
opening? How do the activation mechanisms of SLO1, SLO2 and SLO3 compare
to one another?
To this end, Peng and I decided to screen SLO1, SLO2 or SLO3 CTDs from
different species to identify the best candidates for crystallization. Based on the
results from expression of full-length channels, we expressed constructs in Sf9 as
C-terminal PreScission-GFP-His10 fusions. Most CTDs we tested could be readily
expressed. Together, we identified several promising targets from SLO1, SLO2
and SLO3 that crystallized in initial screens. Refining these crystals to diffractionquality was challenging, and we decided to share the effort. Peng focused on
SLO1, whereas I concentrated on SLO3.
Together with our co-worker Hsiung, who helped us with cell culture,
and under Rod’s continuous guidance, we solved three CTD crystal structures: a
monomeric, Ca2+ bound structure of the human SLO1 (hSLO1) CTD (published
in (193)); a tetrameric, Ca2+-bound structure of the zebrafish SLO1 (zSLO1) gating
ring (published in (194)); and a tetrameric structure of the human SLO3 (hSLO3)
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gating ring. In this chapter, I will describe the structures we obtained of the SLO1
CTDs.
The first structure we solved, the monomeric hSLO1 CTD, defines for the
first time the precise molecular organization of a SLO channel intracellular
domain. Even though in our crystals the hSLO1 CTDs did not assemble in a
gating ring, we could infer the tetrameric, functional organization of the hSLO1
domains by using low-resolution diffraction data from a SLO2.2 crystal. This
oligomeric assembly was later confirmed by the structure of the hSLO1 gating
ring solved by the laboratory of Youxing Jiang at UT Southwestern. This
structure, solved in the absence of Ca2+, defines the ligand-free, “closed”
conformation of the SLO1 gating ring. To understand how the binding of Ca2+ in
the SLO1 CTD changes the conformation of the protein, we solved the tetrameric
gating ring structure of the zebrafish SLO1 CTD bound to its ligand. I will show
how, together, these results illustrate how a Ca2+-driven conformational change
in the SLO1 CTD could translate into the opening of the channel transmembrane
pore.
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3.1 – STRUCTURE OF THE HUMAN SLO1 CA2+ ACTIVATION APPARATUS

3.1.1) Crystallization and structure determination
Residues 341 to 1056 of the human SLO1 sequence were expressed in Sf9
cells. This construct comprises the entire hSLO1 CTD, from the expected first
structural element, with the exclusion of 57 amino acids at the very C-terminus
that are predicted to be unstructured and are not essential for function (151). The
protein was purified and crystallized in the presence of a high concentration of
Ca2+ (50 mM). The native crystals diffracted X-rays to a resolution of 3.0 Å and
belonged to space group P6322, with one monomer per asymmetric unit.
Experimental phases to 3.3 Å were derived from a multi-wavelength anomalous
diffraction experiment with a selenomethionine-containing crystal, and the final
structure was refined to Rwork/Rfree = 0.25/0.28 (Table 1).

3.1.2) Global structure of the hSLO1 CTD
The hSLO1 CTD crystallized in a monomeric form. The structure, shown
in Figure 19a, reveals for the first time the precise molecular organization of the
SLO1 intracellular domain. In particular, the structure shows unequivocally that
the hSLO1 CTD is formed by a tandem of RCK domains (RCK1 shown in blue,
RCK2 in red), as was originally predicted by sequence analysis (24, 122, 151) but
was still matter of debate in the field (195). A salt-bridge interaction between the
side chains of K448 and D481, which was originally identified as a signature of
the presence of RCK1 in the SLO1 CTD (24), can be seen in the structure (Figure
19a). Similar to what is seen in the bacterial MthK channel, each RCK domain has
a bi-lobed shape (Figure 19b): a large N-terminal lobe with a Rossman fold, and a
smaller C-terminal lobe. These two lobes are linked by a helix-turn-helix
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connector (αF-αG in RCK1 and αS-αT in RCK2) that forms the main interface in
the RCK1-RCK2 tandem (Figure 19c). This interface is reminiscent of the “flexible
interface” created through the dimerization of two separate identical RCK
domains in MthK (122).

3.1.3) The Ca2+ bowl
Because of the uncertainty and disagreement in sequence-based models of
the SLO1 channel CTD, there have been different proposals for the placement of
the main SLO1 Ca2+ binding site, the Ca2+ bowl, in RCK2 (151, 195). The hSLO1
CTD structure reveals for the first time the precise location of the Ca2+ bowl
(889QFLDQDDDDDPD900) between the last two β strands (βO and βP, see
Appendix A) of the RCK2 N-terminal lobe. Interestingly, the position of the Ca2+
bowl within the hSLO1 CTD is in sharp contrast with the Ca2+ binding sites of
MthK (Figure 19d). Whereas in MthK Ca2+ binds on the RCK1-RCK2 “flexible
interface”, in hSLO1 the Ca2+ bowl is positioned on the side of RCK2 (Figure 19a).
The experimental electron density for the Ca2+ bowl contained less detail
than most of the experimental map, but the main chain was continuous, and
certain side chain features emerged with cycles of model building and
refinement (Figures 20a, 20b). The model was built on the basis of
crystallographic data alone, independently of information from prior mutational
studies. Interestingly, an atom that is more electron-dense than carbon, nitrogen,
or oxygen accounted for the strongest electron density at the center of the Ca2+
bowl (Figure 20b): we attributed this density as a Ca2+ ion, given its presence at
50 mM concentration in the crystallization solution. Atoms making direct contact
with the Ca2+ ion include two main-chain carbonyl oxygen atoms from Q889 and
D892 and oxygen atoms from the side-chain carboxylate groups of D895 and
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19a

19b

19c

19d

Figure 19: Monomer structure of the human SLO1 CTD. 19a) Cartoon representations
of the hSLO1 CTD showing RCK1 in blue and RCK2 in red. The Ca2+ bowl is colored in
green, and the Ca2+ ion is shown as a yellow sphere. Large disordered segments are
indicated as dashed lines. The N-terminal residue (K343), connecting to the
transmembrane ion-conduction pore, is shown as a magenta sphere. 19b) Sub-domain
organization of RCK1. The organization of the RCK2 domain is identical. 19c) Close-up
view of the αF-αG/αS-αT “flexible” interface. 19d) Ca2+ binding sites in the bacterial
MthK channel (PDB ID 1LNQ).
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20a

20b

20c

20d

Figure 20: The Ca2+ bowl. 20a) Experimental electron density at 3.3 Å in the Ca2+ bowl
region contoured at 1.0 σ. 20b) Weighted 2Fo-Fc electron density at 3.0Å after
refinement contoured at 1.0 σ and 4.0 σ. The final refined model is shown as sticks, with
most side chains removed for clarity. 20c) Structure of the Ca2+ bowl, showing key
residues coordinating the Ca2+ ion (yellow sphere). 20d) Superposition of the Ca2+ bowl
and the Ca2+ binding site from the calpain-1 catalytic subunit (blue) (PDB ID 2R9F). The
Ca2+ ion is shown as a yellow sphere.
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D897 (Figure 20c). In searching the protein database of known structures, we
observed a similar geometry of Ca2+ binding in a high-resolution crystal structure
of calpain, which is an intracellular cysteine protease whose activity is regulated
by Ca2+ (Figure 20d).
Our unbiased model for the Ca2+ bowl structure explains very well the
results of in-depth Ala scanning mutagenesis studies of this region (1). The two
most critical residues for Ca2+ activation, D895 and D897, are both directly
involved in the coordination of the Ca2+ ion in the X-ray structure (Figure 20c).
The third most effective mutation involved D894, which is not in direct contact
with Ca2+ but forms salt bridges simultaneously with R1018 and K1030 in the Cterminal lobe of RCK2. D894 probably plays an important role in stabilizing the
conformation of the Ca2+ bowl. The mutation D896A, on the other hand, had
almost no effect on the channel’s sensitivity to Ca2+ (160). In the X-ray structure,
this side chain is directed out and away from the Ca2+ ion and does not make
other protein contacts.

3.1.4) Quaternary assembly of the hSLO1 gating ring
In our hSLO1 crystals, the CTD is monomeric. However, we expected, by
comparison with RCK-containing bacterial channels such as MthK, that in a
SLO1 channel the CTDs from the four subunits assemble in a tetrameric “gating
ring” at the intracellular face of the membrane (21, 122). Can we infer, from our
monomeric hSLO1 CTD structure, the quaternary assembly of the hSLO1 gating
ring?
To address this question, we used data from another SLO CTD that we
could crystallize: the Na+-activated chicken SLO2.2 (gSLO2.2) CTD. We purified
and crystallized the gSLO2.2 CTD (amino acids 347 to 1201) in the presence of
500 mM Na+. On gel filtration, the CTD eluted as a tetramer, and even under the
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dispersive conditions of SDS-PAGE, the majority of protein migrates as a
tetramer. Thus, the gSLO2.2 CTD forms a very stable tetrameric complex. The
crystals diffracted X-rays to a resolution of 6 Å and were of space group I422,
with one monomer (subunit) in the asymmetric unit (Table 1). Using a poly-Ala
model of the hSLO1 CTD, we obtained a single outstanding solution in
molecular replacement against the gSLO2.2 diffraction data. This solution
indicates that the hSLO1 and gSLO2.2 CTDs must have very similar structures.
By applying the crystallographic symmetry operators, we obtained the tetramer
structure of the hSLO1 CTD (Figure 21a). This objective solution reveals the
quaternary organization of subunits but not its exact atomic details because the
resolution is low and the data are from the SLO2.2 homolog.
Importantly, the biological relevance of the SLO1 gating ring assembly is
supported by previous functional studies. The “assembly interface” between
RCK1 and RCK2 from two adjacent hSLO1 subunits has been studied by doublemutant cycle mutagenesis, and several amino-acid pairs have been shown to
interact (151, 196). These amino acid pairs, including I441-L822, M442-L825, and
I445-L825, are far away from each other in the monomer but are brought close
together in space in the hSLO1 gating ring (Figure 21b).
A comparison of the gating rings from MthK and hSLO1 reveals a striking
difference between the two proteins: whereas in MthK Ca2+ binds at the “flexible
interface” within a RCK pair in the same subunit, in SLO1 the Ca2+ bowl is
located at the “assembly interface” between two adjacent subunits (Figures 21a
and 21c). This result emphasizes the profound functional differences between
RCK-containing homologs, which I will discuss in detail in the final discussion
chapter.
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21a

21b

21c

Figure 21: Gating ring assembly of hSLO1. 21a) Orthogonal views of the tetrameric
hSLO1 gating ring structure using 6.0 Å diffraction data from the homologous chicken
SLO2.2 CTD. View on the right is down the fourfold symmetry axis, with RCK1 in blue
and RCK2 in red. The Ca2+ ions are shown as yellow spheres. The flexible and assembly
interfaces are labeled. 21b) Close-up view of the assembly interface. 21c) Open gating
ring structure from the MthK channel (PDB accession, 1LNQ), viewed down the
fourfold axis.
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3.1.5) Structure of the Ca2+-free hSLO1 gating ring from the Jiang lab
Shortly after we published the structure of the monomeric Ca2+-bound
hSLO1 CTD, the laboratory of Youxing Jiang solved the X-ray structure of the
hSLO1 CTD in a gating ring form, in Ca2+-free conditions (197). To constrain
tetramerization of the CTDs in the crystal, Jiang and co-workers fused the CTD
N-terminus to a leucine-zipper domain from the GCN4 transcription factor that
is known to assemble in a tetrameric coil-coiled helix bundle (197) (Figure 22a).
Using this method, they obtained the tetrameric structure of the hSLO1 CTD
gating ring at 3.1 Å resolution. Surprisingly, the tetrameric coil-coiled domain
was disordered in the crystals, and could not be seen in the structure.
The hSLO1 gating ring structure of Jiang and colleagues (Figure 22b)
matches extremely well with the tetrameric assembly we proposed based on the
gSLO2.2 low-resolution data (193, 197). In particular, the inter-subunit “assembly
interface”, whose atomic details are now defined, is in excellent agreement with
our model. The Ca2+ bowl sequence in this new hSLO1 gating ring structure sits
at the same assembly interface.
The hSLO1 gating ring structure was solved in the absence of Ca2+, thus
representing the unliganded, most likely “closed” conformation of the SLO1
gating ring (197). This important structure therefore provides the first
conformational snapshot of a eukaryotic SLO channel gating ring. Since this
structure defines the Ca2+-free, closed conformation of the SLO1 gating ring, the
next important question to answer was how the binding of Ca2+ influences the
structure of the SLO1 gating ring to promote channel opening. To address this,
we focused our effort on finding conditions to obtain the crystal structure of a
Ca2+-bound SLO1 gating ring. Screening for SLO1 CTDs from many different
species, we discovered that the CTD from the zebrafish SLO1 could be
crystallized in the presence of Ca2+, assembling in a gating ring.
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22a

Figure 22: hSLO1 Ca2+-free, closed gating ring structure. 22a)
Schematic representation of the strategy used by Jiang and
colleagues to stabilize the tetrameric assembly of the hSLO1
CTD: the CTD is fused to a helix from the GCN4 protein forming
a very stable tetrameric coil-coil bundle. 22b) Orthogonal views
of the Ca2+-free, closed hSLO1 gating ring structure.

22b

Figure 23: zSLO1 Ca2+-bound, open gating ring structure. Orthogonal views of the Ca2+bound, open zSLO1 gating ring structure, using the same scale and orientation as in
Figure 22b, The Ca2+ bowl is shown in green and Ca2+ ions as yellow spheres.
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3.2 – STRUCTURE OF THE CA2+-BOUND, OPEN SLO1 GATING RING

3.2.1) Crystallization and structure determination
We used a CTD construct from the zebrafish SLO1 (zSLO1) channel
containing two truncations (194): a truncation removing the disordered Cterminus (as in hSLO1) and a deletion of a large loop in RCK2 that was surfaceexposed and disordered in our previous hSLO1 structure (193). We verified that
these two deletions had no effect on the function of the full channel (194). The
protein crystallized in the P212121 space group, with eight CTD copies in the
asymmetric unit. The crystals diffracted X-rays to 3.6 Å resolution. Initial phases
were determined by molecular replacement using our previous hSLO1 CTD
structure as a search model, and refinement using 8-fold crystallographic
symmetry restraints led to a final model with Rwork/Rfree = 0.26/0.29 (Table 2).

3.2.2) Open structure of the SLO1 gating ring
An important aspect of the zSLO1 gating ring structure is the fact that the
human and zebrafish SLO1 channels are extremely close in both amino acid
sequence and functional properties. The two channels are 93% identical in terms
of sequence, and their sensitivities to Ca2+ are essentially indistinguishable (data
not shown). As a consequence, the ligand-bound, “open” zSLO1 gating ring
structure can be directly compared to the Ca2+-free, “closed” hSLO1 gating ring
structure to assess potential conformational changes underlying Ca2+-mediated
gating.
The overall organization of the open zSLO1 gating ring is similar to the
closed gating ring structure: the RCK1 domains from each subunit form a layer
of the gating ring closest to the membrane, whereas a layer of RCK2 domains
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assembles below (Figure 23). Electron density attributable to a Ca2+ ion is present
in the Ca2+ bowl region, at the “assembly interface” between subunits,
confirming the location of this Ca2+ binding site we originally inferred. The Ca2+
bowl structure itself is nearly identical to that of the monomeric Ca2+-bound
hSLO1 CTD (data not shown).

3.2.2) RCK1 N-lobe movement in the closed-to-open transition
What are the main structural differences between the Ca2+-free, closed and
the Ca2+-bound, open SLO1 gating rings (shown in Figure 24a)? An objective
comparison of conformational differences between the two structures is achieved
by superimposing all Cα atoms of the tetrameric gating rings. Such a
superposition reveals that most of the gating ring undergoes very little
conformational change, especially the bottom RCK2 layer. In particular, only
modest conformational differences occur at the intersubunit “assembly
interface”, except locally near the Ca2+ bowl (Figure 24b). However, the
architecture of one region of the protein changes significantly between the closed
and open structures: the top of the RCK1 layer facing the membrane,
corresponding to the very N-terminal part of the CTD (from secondary structure
elements βA to βC) in the RCK1 N-lobe. This conformational change is shown in
more detail in Figure 24c, where the moving N-terminal region of the gating ring
is highlighted in blue (the rest of the protein is colored in grey, and the front
subunit is removed for clarity): in the Ca2+-bound, open structure, the N-lobe
region of the RCK1 layer moves upward. Importantly, the moving RCK1 N-lobe
region contains the N-terminal CTD residue (Lys 343 in both hSLO1 and zSLO1,
Cα shown as magenta sphere), which is connected to the transmembrane pore in
the channel. It is interesting to note that the Ca2+ ion bound in the Ca2+ bowl is
not directly at the interface between the moving βA-βC RCK1 N-lobe region and
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the rest of the protein (Figure 24d). The overall conformational changes between
the closed an open gating rings are best appreciated by looking at an
interpolative movie where both structures are morphed (movie available at:
http://tinyurl.com/7zx3bwb, part 1): the RCK1 N-lobes appear to “open up” on
the membrane-facing surface of the gating ring in a way akin to petals opening
on a flower. The upward movement of the RCK1 N-lobe between the closed and
open conformations results in a significant increase in the diameter of the SLO1
gating ring (at the position of the N-terminal residues). This is shown in Figure
24e: the bulk of the protein (where conformational changes are only modest) is
colored in grey, the N-terminal region of the RCK1 N-lobes is colored in blue and
the Cα of Lys 343 is shown in magenta. The gating ring diameter, measured at
the Lys 343 Cα, increases from 81 Å in the closed SLO1 to 93 Å in the open SLO1.
Such dilation of the gating ring is reminiscent of what is seen between the closed
and open conformations of the bacterial Ca2+-activated MthK (see Chapter 1).
Again, the remodeling occurring at the inter-subunit interface upon Ca2+
binding is only modest. Instead, the major conformational change of the SLO1
gating ring during the closed-to-open transition is created principally by a
structural rearrangement within individual subunits. The structures of single
subunits from the Ca2+-free hSLO1 and Ca2+-bound zSLO1 are compared in
Figure 25. In Figure 25b, the RCK2 domain is chosen as a point of reference to
illustrate this intra-subunit rearrangement: the subunit structures are superposed
by minimizing the distances between Cα atoms in the RCK2 domain (see Figure
25c where Cα distances are plotted onto the open subunit structure). We can see
that the major conformational change involves the RCK1 N-terminus (βA to βC
in the RCK1 N-lobe), which changes its angle and orientation with respect to rest
of the structure.
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24a

24b

24d

24c

24e

Figure 24: Conformational changes between the closed and open SLO1 gating rings
structures. 24a) Structure of the Ca2+-bound, open gating ring illustrating the result of an
all-atom superposition with the Ca2+-free, closed gating ring. The open gating ring
structure is colored according to the distance between corresponding Cα positions in the
two structures. In the side view (left), the front subunit is removed for clarity. 24b)
Superposition of the assembly interfaces from the closed (grey) and open (colored)
gating ring structures. 24c) Comparison of the closed and open structures using the
same side view as in 24a. The structures are show in grey, except the βA-βC region of
the RCK1 N-lobe, which is highlighted in blue (see text). The N-terminal Lys 343 is
shown as magenta sphere. 24d) Close-up view of the assembly interface and the βA-βC
region of the RCK1 N-lobe. 24e) Closed and open SLO1 gating rings structures viewed
from the top, down the four-fold symmetry axis. The diagonal distance between the Cα
atoms of diametrically opposed N-terminal residues (Lys 343) is indicated.
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25a

25b

25c

Figure 25: Conformational changes between subunits from the closed and open SLO1
structures. 25a) Structure of a subunit from the Ca2+ bound, open SLO1 gating ring. The
N-terminal Lys 343 is shown as magenta sphere. 25b) Same views as in 25a) showing a
superposition of subunits from the open (in red) and closed (in black) SLO1 gating rings,
aligning the RCK2 domains. Parts where the two structures align very well are shown in
wire representation. The βA-βC region of the RK1 N-lobe, which orientation changes
significantly between the two structures, is highlighted by showing a cartoon
representation of secondary structure elements. The N-terminal Lys 343 is shown as a
sphere. 25c) Cartoon representation of the open SLO1 subunit colored according to the
distance between Cα positions between the open and closed structures in the
superposition shown in 25b).
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3.3 – A STRUCTURAL MODEL FOR SLO1 CA2+-DRIVEN OPENING

Are the conformational changes we observe between the Ca2+-free and
Ca2+-bound SLO1 gating ring structures compatible with the opening and closing
of a K+ channel? In other words, with these two conformations in hand, can we
reconstruct the transition between a closed and an open SLO1 channel using our
prior structural knowledge of K+ channels?
To address this question, we constructed structural models of the closed
and open conformations of a SLO1 channel using the SLO1 gating ring structures
and the structures of closed (KcsA) and open (MthK) bacterial K+ channel pores.
The Ca2+-bound structure of MthK served as the first reference for our model. We
started with this open MthK structure and replaced its gating ring with the Ca2+bound zSLO1-channel gating ring. This step involved alignment of the four-fold
axis followed by minimization of the distance between the N terminus of the
SLO1 gating ring and the corresponding position within the MthK gating ring
structure, through least-squares minimization of the distances between residues
343 of all four SLO1 subunits and the corresponding residues, 116, of all four
MthK subunits. The resulting model of an open SLO1-channel gating ring with
an open K+ pore is shown in Figure 26a. The distance between the C-terminal
residue of the inner helix of the pore and the N-terminal residue of RCK1, which
was not constrained in making the model, is 33 Å. In a second step, we replaced
the open MthK pore with the closed KcsA pore by aligning the invariant
selectivity filter, and replaced the Ca2+-bound zSLO1 gating ring with the Ca2+free hSLO1 gating ring by aligning the nearly invariant RCK2 layer. The
resulting model of a Ca2+-free SLO1 gating ring with a closed K+ pore is shown in
Figure 26b. In this closed model, the distance between the C-terminal residue of
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the inner helix and the N-terminal residue of RCK1, which again was not
constrained in making the model, is 32 Å. In this analysis, the similar pore-togating-ring distance (32 Å) in the open model and the closed model suggests that
the magnitude of conformational change observed within the gating ring is
compatible with the magnitude of change known to occur in the pores of other
kinds of K+ channels. This result reinforces the conclusion that the Ca2+-free
hSLO1

and

Ca2+-bound

zSLO1

gating

ring

structures

represent

two

conformations directly relevant to Ca2+-driven gating in SLO1 channels. An
interpolative

movie

illustrating

our

analysis

is

available

at

http://tinyurl.com/7zx3bwb (part 2).

Altogether, the SLO1 CTD structures we solved offer important new
insights into the mechanism of Ca2+ gating in SLO1 channels. The first structure
of the monomeric hSLO1 CTD describes the precise molecular organization of
the SLO1 Ca2+-activation apparatus, formed by a tandem of RCK domains. The
structure also defines the precise position of the Ca2+ bowl, on the side of RCK2,
which has an unexpected structural consequence: in SLO1 channels, this main
Ca2+ binding site is located at the assembly interface between subunits, in sharp
contrast with the position of the ligand binding site in bacterial RCK-containing
channels. By solving the structure of the Ca2+-bound zSLO1 gating ring, and
comparing it with the structure of the Ca2+-free hSLO1 gating ring from the Jiang
lab, we now have the first molecular snapshots of the conformational changes
involved in SLO1 Ca2+-driven opening. During the closed-to-open transition, a
major conformational change occurs in the RCK1 N-lobes facing the membrane,
leading to a dilation of the gating ring that we can directly link to the opening of
the transmembrane K+-conducting pore.
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CK2 are labelled. Large disordered regions are indicated by dotted lines.

aF, aD and aQ are labelled.

ng causes a shrinking of the ring’s height and an expansion of
ameter12 (Supplementary Movie 2). By contrast, in the BK gating
Ca21 binding causes only the layer facing the membrane to
rgo a substantial conformational change (Supplementary Movie 1).

This comparison presents a fascinating example in which the evoluti
of molecular structure has given rise to new or modified mechani
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the gating rings. Yellow spheres represent Ca2+ ions. The N-terminal residues of RCK1
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and the C-terminal residues of the inner helices are shown as black spheres. 26b) Views
of the BK channel model with a Ca2+-free gating ring and a closed pore. Here, the Ca2+bound gating ring in 26a) is replaced by the Ca2+-free gating ring (PDB accession 3NAF)
and the open MthK pore in 26a) is replaced by the closed KcsA pore (PDB accession
1K4C). The inner helix from KcsA is truncated to match the length in MthK.
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This work paves the way for a precise molecular understanding of Ca2+
activation in SLO1 channels. In particular, we can now directly address how the
energy of Ca2+ binding is transduced into the conformational changes we observe
(and ultimately into mechanical work to open the channel pore) by designing
specific experiments based on our structural knowledge. At another level, our
data and analysis now define the precise conformation of two end points in the
Ca2+-induced gating conformational transition of the SLO1 gating ring. Given the
large conformational change that occurs upon Ca2+ binding, it should in principle
be now possible to identify small molecules that stabilize one conformation or
the other, with direct therapeutic implications considering the vast range of
disorders linked to SLO1 function.
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CHAPTER FOUR:

CRYSTAL STRUCTURE OF THE HUMAN SLO3 CTD:
IMPLICATIONS FOR PH SENSING IN SLO3 CHANNELS
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Our work on SLO1 channels defined the conformational changes
occurring at the intracellular level during Ca2+-activation: the upward movement
of the RCK1 N-lobe region upon Ca2+ binding triggers opening of the
transmembrane ion-conduction pore. What, then, about other channels in the
SLO family? Are the mechanistic principles of intracellular activation conserved?
To address this question, I turned to the pH-sensitive, alkalization-activated
SLO3 channels, which are the closest homologs of SLO1 (see Chapter 1). I
focused on the human and mouse SLO3 channels, aiming at understanding the
molecular mechanisms of pH sensing in these proteins. To this end, I solved a
structure of the human SLO3 gating ring. Interestingly, a comparison with the
SLO1 gating ring structures reveals that the organization of the N-lobe region of
the RCK1 domains in the tetrameric hSLO3 gating ring matches closely the open
conformation of the SLO1 gating ring.
To further understand the mechanistic principles of pH gating in SLO3 channels,
I performed functional mutagenesis with the goal of identifying protein residues
responsible for pH sensing. Whereas the direct functional analysis of the human
SLO3 channel proved prohibitively challenging because of low protein
expression, I could identify the residues responsible for pH sensing in the mouse
SLO3 homolog. These residues are located at the interface between the RCK1 Nlobe and RCK2. This lead me to propose a model for pH sensing in the mouse
SLO3 channel in which the direct effect of pH increase is to drive the movement
of the RCK1 N-lobes to open the channel. Surprisingly, the protein residues
forming the pH sensor in mouse SLO3 are not conserved in SLO3 channels from
other species. SLO3 channels, which are specific to mammalian sperm cells, offer
a striking example of the extremely fast evolution of proteins specialized in
reproduction.
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4.1 – STRUCTURE OF THE HUMAN SLO3 GATING RING

4.1.1) The human SLO3 channel is activated by an increase in intracellular pH
As I presented in Chapter 1, SLO3 channels are specific to mammalian
sperm cells, where variations in intracellular pH directly regulate many
physiological processes (32). So far, only the function of the mouse homolog of
SLO3 has been studied in detail. Electrophysiological studies have shown that, in
mouse sperm cells, SLO3 currents are activated by an increase in intracellular pH
(1-3). Furthermore, the pH-dependence of mSLO3 currents has been
characterized in depth using heterologous expression (95, 198). I became
interested in the human SLO3 (hSLO3) homolog because of its direct relevance to
human physiology, but hSLO3 channels had never been studied functionally. I
therefore decided to first characterize the pH dependence of hSLO3 currents,
using heterologous expression.
I expressed SLO3 channels in Xenopus laevis oocytes, a standard
expression system for electrophysiological studies (199). Xenopus oocytes are
extremely large single cells (>1 mm diameter) in which RNA coding for an ion
channel (or other protein of interest) can be directly injected. The oocyte cellular
machinery then induces expression of the channel, and the corresponding
currents can be studied by electrophysiological techniques. To study intracellular
activation of SLO3 channels I used the inside-out patch-clamp technique, where
a patch of the oocyte membrane is isolated within a glass pipette in a
configuration exposing its intracellular surface. The intracellular solution applied
to such an “inside-out” patch can thus be controlled, while the corresponding
electrical currents are recorded.
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The results of such recordings are presented in Figure 27a, which shows
currents of a single inside-out patch from an hSLO3-expressing oocyte. The
currents are elicited by a series of voltage steps from -140 to + 180 mV. Clearly,
the hSLO3 currents are pH-sensitive: as the intracellular pH is increased, the
current density increases as well. For comparison, the same experiment
performed on the mouse mSLO3 homolog is shown in Figure 27b. Plotting the
maximum SLO3 current (i.e., at +180 mV) as a function of H+ concentration
reveals that the pH dependences of hSLO3 and mSLO3 channels are extremely
similar (Figure 27c). However, comparing the total amount of current between
hSLO3 and mSLO3 reveals an important difference between these two channels:
in Xenopus oocytes, hSLO3 channels are poorly expressed compared to mSLO3
(compare the current scale between Figures 27a and 27b). This property makes
the functional analysis of hSLO3 technically challenging. Using other expression
systems (HEK cells or Sf9 cells) for electrophysiology did not overcome this
problem (data not shown). In HEK cells, tagging hSLO3 with GFP shows an
accumulation of GFP signal in the peri-nuclear region, suggesting that the hSLO3
protein is difficultly expressed at the plasma membrane (data not shown).
These functional studies on human SLO3 channels expressed in Xenopus
oocytes establish for the first time that hSLO3 currents are alkalization-activated,
with a pH-dependence very similar to the well-studied mSLO3 homolog.

4.1.2) Crystallization of the hSLO3 CTD and structure determination
Based on these results, I became interested in understanding the
molecular mechanisms of pH sensing in mouse and human SLO3 channels. To
this end, I decided to study the structure of cytoplasmic domains (CTDs) from
these channels, expressed in Sf9 cells as described in Chapter 3. Only the hSLO3
CTD could be expressed at levels compatible with structural analysis

	
  

83

27a

27b

27c

Figure 27: pH activation of human and mouse SLO3 channels. 27a) Representative
inside-out patch currents recorded from a Xenopus oocyte expressing human hSLO3
channels. Channel opening was elicited by voltage pulses from -140 to +180 mV in 20
mV increments (see inset, holding voltage: -60 mV). The hSLO3 patch was sequentially
bathed in solutions of increasing pH. The capacitive currents are masked for clarity. 27b)
Recordings as in 27a), showing currents from a mouse mSLO3 patch. 27c). 27c) Plot of
maximal current at +180 mV as a function of intracellular [H+], normalized to current at
pH 8.5. Error bars show the standard error of the mean (hSLO3, n=3; mSLO3, n=5). pH
dependence is fitted to a Hill curve.
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(interestingly, the relative expression levels of the CTDs from hSLO3 and
mSLO3 is opposite the expression levels of the whole channels).
Preliminary biochemical analysis showed that the hSLO3 CTD is most
stable at high pH, and assembles as a tetramer during purification (data not
shown). Crystals were obtained using poly-ethylene-glycols (PEGs) as
precipitants, and PEG chain length was critical to optimize diffraction. The best
crystals were grown using PEG12000 and diffracted X-rays to ~3.3 Å resolution.
The hSLO3 CTD crystallized in the I222 space group, containing two CTD
subunits in the asymmetric unit.
Diffraction of X-rays by these crystals was very anisotropic, and analysis
revealed that diffraction in the a* and b* directions of the reciprocal cell are the
weakest. The final dataset I used for structure determination makes use of data
recorded from two different crystals, which varied in their degree of anisotropy.
Reflection data were merged and scaled together in the final dataset. The scaled
dataset was anisotropically corrected to resolution limits of 3.8, 3.4 and 3.3 Å
along the reciprocal cell directions a*, b*, and c*, respectively, using the
diffraction anisotropy server at UCLA (200). The final model was refined against
data to 3.4 Å resolution.
The structure was solved by molecular replacement using the monomeric
hSLO1 CTD structure as a search model. Importantly, the first step of structure
refinement required rigid-body adjustment of the RCK1 N-lobe. The final model
was refined to Rwork/Rfree = 0.25/0.27 (Table 3). Application of the
crystallographic symmetry operators revealed that the hSLO3 CTDs assemble in
a gating ring in the crystals.
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4.1.3) Structure of the hSLO3 gating ring
The structure of the hSLO3 gating ring is shown in Figure 28a. The overall
domain organization is similar to the SLO1 gating structures: in the hSLO3
gating ring, RCK1 domains form an upper layer facing the membrane (with the
RCK1 N-lobe regions at the top) and RCK2 domains form a layer at the bottom.
The secondary structure elements forming the “assembly interface” between
subunits are conserved between hSLO3 and SLO1: helices αD and αE in the
RCK1 domain of one subunit contact the helix αQ in the RCK2 domain of an
adjacent subunit (see Figure 28b). A notable difference between SLO1 and hSLO3
occurs in the RCK2 region corresponding to the Ca2+ bowl in SLO1: the
equivalent residues in hSLO3 form an extended alpha helix (named αQ’), which
becomes part of the inter-subunit assembly interface (Figure 28b). The structure
of an isolated subunit from the SLO3 gating ring is shown in Figure 28c. The
overall domain organization of the hSLO3 CTD subunit is the same as for the
SLO1 CTD subunit, showing a tandem of RCK domains brought together by a
large interface, which principally consists of the helix-turn-helix motifs from the
RCK1 and RCK2 domains.

4.1.3) Comparison with the SLO1 gating ring structures
The sequence of the human SLO3 channel shares a high degree of
homology with the sequence of SLO1 channels. In particular, the sequence of the
human SLO3 CTD is 42% identical to the sequence of the CTD from either
human or zebrafish SLO1 channels. How, then, does the structure of the hSLO3
gating ring compare with either the closed or open structure of the SLO1 gating
ring?
Before we examine the structures of the hSLO3 and closed or open SLO1
gating rings, let us first compare the structures of isolated subunits from each of
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28a

28b
28c

Figure 28: Structure of the human SLO3 gating ring. 28a) Cartoon representation of the
hSLO3 gating ring structure with RCK1 colored in blue and RCK2 in red. The gating is
viewed from the side (left) and form the top, down the four-fold symmetry axis (right).
The inter-subunit assembly interface and intra-subunit RCK1-RCK2 flexible interface are
labeled. 28b) Close-up view of the hSLO3 assembly interface, with secondary structure
elements labeled. In SLO3 an extended helix, αQ’, is present in the region equivalent to
the Ca2+ bowl in SLO1. 28c) Cartoon representation of a single subunit from the hSLO3
gating ring. The RCK1 domain is colored in blue, RCK2 is colored in red and the Nterminal residue (Lys 331, equivalent to Lys 343 in SLO1) is shown as a magenta sphere.
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these tetrameric rings. The overall sub-domain organization of the hSLO3 CTD
subunit is the same as in SLO1: both RCK domains are formed by a N-terminal
lobe with a Rossman fold topology, followed by a helix-turn-helix motif and a Cterminal lobe (Figure 29a). However, the relative orientation of the sub-domains
in the hSLO3 subunit is quite different than in the closed or open SLO1
structures. A comprehensive comparison reveals that, in the hSLO3 isolated
subunit, the RCK1 N-lobe sub-domain changes its orientation with respect to the
rest of the structure compared to either the closed or open conformation of the
SLO1 subunit. This is shown in Figure 29b, where the SLO1 isolated subunits are
aligned onto an hSLO3 subunit by superimposing the Cα atoms of all residues
except the RCK1 N-lobe. The regions excluding the RCK1 N-lobe align very well.
However, the orientation of the hSLO3 RCK1 N-lobe matches neither
conformation of the SLO1 subunit.
If we now compare the structures of the entire gating rings between
hSLO3 and the two conformations of SLO1, the direct result of the re-orientation
of the RCK1 N-lobes in the individual hSLO3 subunits is that the hSLO3 ring
does not align well with either the open or closed SLO1 rings. An objective
comparison of these structures is achieved by superimposing all Cα atoms of the
tetrameric gating rings. The total Cα RMSDs (calculated using all Cα from a
tetrameric ring) of these superpositions are very high (4.7 Å for the hSLO3/open
SLO1 superposition; 5.9 Å for the hSLO3/closed SLO1 superposition). However,
an interesting difference can be noticed in the region formed by the RCK1 Nlobes from all four subunits (which I will from now on refer to as the “RCK1 Nlobe layer”). In the superposition using all Cα atoms, the RMSD in the RCK1 Nlobe layer (RMSD calculated using Cα belonging to the RCK1 N-lobes from all
four subunits) between the hSLO3 and open SLO1 gating rings is 3.9 Å, versus
6.0 Å when hSLO3 is compared to the closed SLO1 conformation. This is shown
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29a

29b

29c

Figure 29: Comparison between the structure of individual subunits from the hSLO3
and SLO1 gating rings. 29a) Sub-domain architecture of the hSLO3 subunit, shown for
RCK1. The sub-domain organization of RCK2 is identical. Magenta sphere shows the
position of the N-terminal residue. 29b) Superposition of subunits from hSLO3 (red) and
the open conformation of the SLO1 gating ring (black). The subunits were superimposed
using the Cα of all atoms excluding the RCK1 N-lobe region. 29c) Same as 29b) but using
the closed conformation of the SLO1 gating ring.
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in Figure 30. In Figure 30, the all-Cα superimposed structures are viewed looking
from the top of the gating ring, down the four-fold symmetry axis, and the RCK1
N-lobe layers are shown in ribbon representation (SLO3 colored red, SLO1
colored black). For the rest of the gating ring, where the structures do not align
well, only the SLO3 structure is shown, in grey. Qualitatively, the objective allCα superpositions show that the overall structure of the hSLO3 gating is
significantly different from either conformation of the SLO1 gating ring, but that
the layer formed by the RCK1 N-lobes from all four hSLO3 subunits seems to
align relatively well with the equivalent region of the open, but not the closed,
conformation of SLO1. Another important aspect, independent of any
superposition, can be seen in Figure 30a. Measured from equivalent N-terminal
residues (K332 in hSLO3, K343 in SLO1, shown as spheres), the diameter of the
hSLO3 gating ring (94 Å) matches almost exactly the diameter of the open SLO1
gating ring (93 Å, versus 81 Å in the closed SLO1 gating ring).
To further compare the structure of the RCK1 N-lobe layer between the
tetrameric hSLO3 and SLO1 gating rings, I performed another structural
alignment by superimposing the Cα atoms in this region (using all four
subunits). The results are shown in Figure 31. This analysis reveals that, in the
hSLO3 tetrameric gating ring, the structure of the RCK1 N-lobe layer matches
very closely the corresponding region in the open conformation of the SLO1
gating ring (RMSD, measured using atoms from all four subunits: 2.7 Å),
whereas the rest of the structures align quite poorly (RMSD, measured using
atoms from all four subunits: 6.5 Å) (Figures 31a, 31c). When the closed
conformation of the SLO1 gating is used in the same superposition, no significant
alignment is observed in any part of the structures (Figures 31b, 31c).
The hSLO3 structure was solved by molecular replacement using the
structure of the monomeric Ca2+-bound hSLO1 CTD (PDB ID 3MT5) as search
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30a

30b

RMSD RCK1 N-lobes
3.9 Å

RMSD other parts
5.0 Å

RMSD RCK1 N-lobes
6.0 Å

RMSD other parts
5.9 Å

hSLO3 / open SLO1

hSLO3 / closed SLO1

Global RMSD
4.7 Å

Global RMSD
5.9 Å

Figure 30: All-Cα atoms superposition of the hSLO3 and open/closed SLO1 gating
rings. 30a) Objective superposition of the hSLO3 and open SLO1 gating rings by
aligning all Cα from the tetrameric structures. The gating rings are viewed from the top,
down the four-fold symmetry axis. The RCK1 N-lobe regions from the hSLO3 (in red) or
the open SLO1 (in black) gating rings are shown as ribbon. The rest of the protein, for
which the superposition is poor and is not shown, is drawn as a grey cartoon
corresponding to the hSLO3 gating ring structure. The N-termini are shown as spheres.
30b) Same as 30a), but using the closed SLO1 structure.
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6.5 Å

31a
90˚
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RCK1 N-lobes
2.7 Å

hSLO3 / open SLO1
Global RMSD: 5.8 Å
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other parts
6.9 Å

31b
90˚

RMSD
RCK1 N-lobes
5.2 Å

hSLO3 / closed SLO1

31c

Global RMSD: 6.5 Å

hSLO3 / closed SLO1

hSLO3 / open SLO1
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0.3

0.3

14 Å

13 Å

Figure 31: RCK1 N-lobes superposition of the hSLO3 and open/closed SLO1 gating
rings. 31a) Superposition of the hSLO3 and open SLO1 gating ring structures by
aligning the RCK1 N-lobes from all four subunits. The RCK1 N-lobe regions from the
hSLO3 (in red) or the open SLO1 (in black) gating rings are shown as ribbon. The rest of
the protein, for which the superposition is poor and is not shown, is drawn as a grey
cartoon. The N-termini are shown as spheres. 31b) Same as 31a), but using the closed
SLO1 structure. 31c) Cartoon representation of the hSLO3 gating ring colored according
to the distance between Cα positions in the same superpositions as in 31a) or 31b). Same
view as in 31a) or 31b), right. The gating ring N-terminus is shown as a magenta sphere.
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model. The conformation of this Ca2+-bound hSLO1 monomer is very similar to
the conformation of an isolated subunit from the open SLO1 gating ring. Since
the hSLO3 structure was solved at relatively low resolution (3.4 Å), I wanted to
ensure that the conformation of the SLO1 search model had no effect on the final
hSLO3 structure, and especially on the architecture of the RCK1 N-lobe. To test
this, I used an unbiased molecular replacement strategy in which the SLO1
subunit used as search model is separated into two independent parts: the RCK1
N-lobe on the one hand, and the rest of the subunit on the other. In a first round
of molecular replacement, only the part excluding the RCK1 N-lobe is used as
search model (searching for two copies, because the asymmetric unit in the
hSLO3 crystals contains two protomers). This gives a first solution, where the
position of the non-RCK1 N-lobe atoms are defined. In a second round of
molecular replacement, this first solution is fixed and only the isolated RCK1 Nlobe is used as searched model (again, searching for two copies). This gives a
final solution representing the whole hSLO3 subunit. The hSLO3 gating ring
structure can then be generated by applying the crystallographic symmetry
operators. The result of this unbiased molecular replacement strategy shows that
the final hSLO3 gating ring structure is independent of whether the closed or
open conformation of a SLO1 subunit is used as search model. In each case, the
final architecture of the hSLO3 gating ring (in particular in the RCK1 N-lobe
layer) matches the refined structure that I described in this chapter (data not
shown).
Altogether, the hSLO3 gating ring structure resembles most closely the
open conformation of the SLO1 gating ring. Most importantly, the architecture of
the RCK1 N-lobe layer in hSLO3 coincides with the architecture observed in the
open SLO1 gating ring, and the overall diameters of the hSLO3 and open SLO1
gating rings are identical. Since in SLO1 channels the orientation of the RCK1 N-
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lobe layer is the main structural determinant of the open vs. closed state of the
gating ring, it is likely that the hSLO3 structure represents the open conformation
of the hSLO3 gating ring1. The fact that hSLO3 and SLO1 channels are highly
homologous in amino acid sequence reinforces this hypothesis. In particular, the
length of the linkers connecting the CTDs to the transmembrane pore is
absolutely conserved, so that the identical diameters of the hSLO3 and open
SLO1 gating rings could drive the opening of the pore in a similar manner.
It is interesting to stress that, whereas the architecture of the RCK1 N-lobe
layer is conserved between the hSLO3 structure and the open conformation of
SLO1, in the rest of the gating ring the hSLO3 and open SLO1 structures do not
align. In particular, the architecture of the “bottom layer” formed by the RCK2
domains (shown in grey in Figure 31a) is very different in these two gating rings.
Again, this is a direct consequence of the different positioning of the RCK1 Nlobe within the individual subunits of these two structures. To “compensate” for
this re-positioning, the specific orientation of subunits with respect to one
another is changed between the hSLO3 and open SLO1 tetramers so as to keep
the architecture of the RCK1 N-lobe layer, but not of the rest of the gating ring,
unaltered. This raises the possibility that the specific architecture of the RCK1 Nlobe layer is constrained between SLO1 and SLO3 channels, which I will develop
more in the final discussion chapter.

	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
1	
  The hSLO3 crystals were grown in a solution with an initial pH of ~6.8, at which hSLO3

channels are expected to be mostly closed. However, the actual pH in a protein crystal is hard to
define and, maybe most importantly, the pH dependence of the isolated hSLO3 gating ring does
not have to be the same as for the entire channel. The value of pH in which the crystals were
grown might therefore be somewhat irrelevant to estimate whether the structure represents the
open or closed conformation of the hSLO3 gating ring based on the pH dependence of hSLO3
currents.	
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In conclusion, the structure of the hSLO3 gating ring provides the first
molecular snapshot of the pH-sensing unit from a SLO3 channel. However, a
mechanistic understanding of how an increase in intracellular pH drives the
opening of SLO3 channels is still lacking. To address this important question, I
decided to perform functional mutagenesis on SLO3 channels with the goal of
identifying the amino acid residue(s) responsible for pH sensing. Unfortunately,
due to the very low expression of hSLO3 currents in heterologous systems, direct
mutagenesis analysis of hSLO3 channels proved to be prohibitively challenging.
As a consequence, I decided to perform mutagenesis in the mouse mSLO3
homolog, whose pH dependence is very similar to hSLO3. Furthermore, the two
channels share a significant percentage of sequence identity (67 %).
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4.2 – MECHANISM OF PH SENSING IN MOUSE SLO3 CHANNELS

4.2.1) pH sensing residues in mSLO3
To identify the pH sensing residues in mouse SLO3 channels, I modified
single amino-acids by introducing point mutations in the mSLO3 sequence
(usually to alanine), and analyzed the pH-dependence of the corresponding
mutant channels by electrophysiology in Xenopus oocytes. I focused my analysis
on amino-acids containing protonable side-chains (namely: Asp, Glu, His, Lys
and Arg). I tested the effect of mutations in different regions of the mSLO3 CTD,
insisting on protonable residues located at protein interfaces that could be
important for channel function: the inter-subunit assembly interface (in
particular, I mutated all protonable residues around a large region
corresponding to the Ca2+ bowl in SLO1), the RCK1-RCK2 helix-turn-helix hinge,
and the interface between the RCK1 N-lobe and the rest of the protein structure.
Out of > 40 positions tested (see Appendix B), mutations of only two
residues had a significant effect on the pH dependence of mSLO3: His 417
located in the RCK1 N-lobe, and Asp 912 located in the RCK2 helix-turn-helix
motif. The pH dependences of the mSLO3 D912N and H417A mutants are shown
in Figure 32. All traces are normalized to the maximal current obtained at pH 8.5
([H+] = 3.2 10-9 M). The pH dependence of mSLO3 D912N is dramatically
impaired compared to wild-type, whereas the H417A mutation abolishes all pH
sensitivity in the range studied here (pH 7.2 to 8.5, [H+] 6.3 10-8 M to 3.2 10-9 M).
A more detailed analysis of the functional effects of the D912N and H417A
mutations in mSLO3 is still under way. However, a qualitative observation
suggests that the mutant D912N or H417A mSLO3 channels are constitutively
more open than wild-type mSLO3. This can be observed in experiments in which
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relative current at +180 mV
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mSLO3 D912N
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Figure 32: D912N and H417A mutants in mSLO3 channels. pH dependences of wildtype, and mutant D912N and H417 channels are shown as in Figure 27. Each point is the
mean of two independent measurements.
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the resting membrane potential of intact Xenopus oocytes expressing the different
channels is measured. In ND-96 buffer approximating physiological conditions
(96 mM extracellular [Na+], 2 mM extracellular [K+]), the presence of
constitutively open K+ channels in the oocyte membrane would drive the resting
potential to more negative values (the reversal potential for K+ in this system is
around -100 mV). This is precisely what is observed with the D912N and H417
mutants. Whereas oocytes expressing wild-type mSLO3 channels have a typical
resting potential of -40 mV, oocytes expressing either the D912N or H417A
mutants have typical a resting potential of -70 mV. Importantly, this is not due to
an increase in expression of the mutant channels compared to wild-type (data
not shown). Rather, the D912N and H417A mutant channels appear to be
significantly more open than wild-type mSLO3 under resting conditions.

4.2.2) H417 and D912 in the mSLO3 CTD, and conservation in other SLO3
channels
The functional effects of the D912N and H417A mutations in mSLO3 raise
the possibility that these residues form the “pH sensor” of mSLO3 channels, in
other words that the protonation state of either or both D912 and H417 side
chains is the molecular determinant for pH sensing in mSLO3. Can we evaluate
this hypothesis by looking at where these residues are located within the mSLO3
CTD? And are these residues conserved in other SLO3 channels, such that the
pH sensor they might be the same in other species?
D912 is conserved in all SLO3 channels, but also in SLO1 channels.
However, H417 is surprisingly not conserved in the SLO3 family: in all other
species for which the SLO3 sequence is known, the residue at position 417 is a
non-protonable proline (Figure 33a). Does this mean that H417 is unlikely to be
part of the pH sensor in mouse SLO3 channels? As I will describe next, I believe
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that H417 is indeed the pH sensing residue in the mouse SLO3 protein (i.e. the
residue which protonation state directly changes upon pH increase, leading to
channel opening). Rather, the non-conservation of H417 is most likely the
consequence of two processes: on the one hand, the inherent structural and
functional plasticity of the gating ring scaffold, and on the other hand, the
extremely rapid evolution of proteins specialized in reproduction (such as the
sperm-specific SLO3), which is well described and believed to be an important
driving force for speciation, limiting cross-species fertilization (201, 202). I will
discuss this idea further in the final discussion chapter.
Since H417 is not conserved in the human SLO3 channel (where it is a
proline), it is difficult to directly use the hSLO3 structure to understand the
functional effects of the H417A mutation in mSLO3. The structure of the SLO1
CTD, on the other hand, offers important insights. In SLO1, the residue
corresponding to mSLO3 H417 is a lysine (K428 in hSLO1), conserved across
SLO1 species. K428 is located in the loop between secondary structure elements
βD and αD in the RCK1 N-lobe. Interestingly, in the SLO1 CTD structure (in the
closed as well as open state), K428 is involved in a salt bridge interaction with the
conserved aspartate corresponding to mSLO3 D912 (D921 in hSLO1). The K428D921 salt-bridge makes a direct structural connection between the bottom of the
RCK1 N-lobe and the RCK2 domain in SLO1 channels. The position of these
residues is shown in Figure 33b, where I used the structure of the Ca2+-free
hSLO1 CTD structure and replaced K428 with a histidine. In hSLO3, the presence
of a proline at position 417 changes dramatically the structure of the βD-αD loop,
which kinks away from RCK2 (Figure 33c). The specific architecture of this loop
in hSLO3 is most likely due to the unique structural properties of proline
residues. It is possible that, in mSLO3, the presence of a histidine induces a loop
conformation resembling what is seen in SLO1.
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Figure 33: A model for pH gating in mSLO3 channels. 33a) Sequence comparison of
SLO3 channels at the position corresponding to H417 in mSLO3. In all other species, this
residue is a proline. 33b) In SLO1 channels, the residues equivalent to mSLO3 H417 and
D912 form a salt-bridge interaction. The structure from a single subunit of the Ca2+-free
hSLO1 gating ring is shown, with K428 (equivalent to mSLO3 H417) replaced by an
histidine. The putative salt-bridge formed by H417 and D912 in mSLO3 connects the
RCK1 N-lobe and the RCK2 domain in a single subunit. 33c) Architecture of the βD-αD
loop in the hSLO3 structure. 33d) Mechanistic model for pH gating in mSLO3 channels.
As the intracellular pH increases, H417 is deprotonated and the salt-bridge interaction
with D912 is lost, leading to an upward movement of the RCK1 N-lobe domain.
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4.2.3) A model for pH sensing in mouse SLO3 channels
The structural arrangement shown in Figure 33b offers a natural
hypothesis for the mechanism of pH sensing in mouse SLO3 channels. A saltbridge interaction between D912 an H417 would be ideally located to control the
position of the RCK1 N-lobe with respect to the rest of the mSLO3 CTD. In SLO1,
the major conformational change during the closed-to-open transition involves
precisely the movement of the RCK1 N-lobes with respect to the rest of the
gating ring. Furthermore, the similar arrangement of the RCK1 N-lobes between
the hSLO3 and open SLO1 gating ring structure suggests that pH gating in SLO3
channels could involve a repositioning of the RCK1 N-lobes similar to what is
observed in SLO1 channels. Therefore, I propose that the salt-bridge interaction
between D912 and H417 in the CTD subunits form the pH-sensitive element of
the mSLO3 gating ring. Which of these two residues could then be the actual pH
sensor? H417 is perfectly suited to be the pH-sensing residue, since the histidine
side-chain has the unique property of having a pKa falling right into the
physiological range of pH in cells (203).
These observations lead me to propose a model for pH sensing in mSLO3
channels shown in Figure 33d. At low pH, H417 is protonated and makes a saltbridge interaction with D912, stabilizing the “closed” conformation of the SLO3
gating ring. As pH is increased, H417 is deprotonated, the high-energy saltbridge interaction is lost and the RCK1 N-lobe is free to change its angle with
respect to the rest of the structure, leading to channel opening.
This model is based on three aspects revealed by the functional
mutagenesis studies I presented. First, D912 and H417 are the only amino-acids
whose mutation affected the pH-dependence of mSLO3 currents in a rather
extensive mutagenesis screen. Second, the H417A mutation completely abolishes
pH sensing in mSLO3 whereas D912N has a less dramatic effect, compatible with
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the idea that the protonation state of H417 is the main determinant of mSLO3 pH
dependence. Third, the H417A and D912N mutant channels appear to be
constitutively more open than wild-type mSLO3. This is precisely what would
happen in the context of the model, since in the absence of charges at positions
417 or 912, the salt-bridge interaction would be lost and the low-pH, “closed”
state of the mSLO3 channel would be constitutively destabilized.
Additional experiments are needed to verify the model. In particular, a
crucial prediction would be that mutations replacing H417 by an arginine or a
lysine (H417R or H417K), which side-chains are expected to be constitutively
protonated in the range of pH considered here due to their high pKa, would lock
the corresponding mutant mSLO3 channels in a low-pH-like, “closed”
conformation since the salt bridge would be constitutively present. Another test
could involve functional experiments were positions 417 and 912 would crosslinked in a mutant mSLO3: upon cross-linking, the mutant channels should be
“closed”. These additional experiments are still ongoing.

4.2.4) An experimental system for functional mutagenesis of hSLO3 channels
If H417 is indeed the pH sensing residue in mSLO3, the fact that it is not
conserved in the sequence of other SLO3 channels (in particular hSLO3) is quite
surprising, especially considering that the pH dependences of mSLO3 and
hSLO3 are very similar (recall Figure 27). To understand how mouse and human
SLO3 channels could share almost identical pH sensitivities using different
molecular mechanisms, we need to understand the molecular details of pH
sensing in the human hSLO3 channel. As I described above, the low expression
of hSLO3 in heterologous systems prevents mutagenesis experiments in practice.
Such low functional expression could be explained by the fact that a specific
cofactor or interaction partner, missing in heterologous systems, is required for
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efficient protein folding and/or trafficking of hSLO3 channels. Very recently, a
study identified a new protein interacting with mSLO3 channels in mouse sperm
cells (106). This protein, LRRC52, belongs to the family of leucine-rich-repeatcontaining membrane proteins, which also includes a protein known to interact
with SLO1 (83). LRRC52 is present in the human genome, and I decided to test
whether the human hLRRC52 interacts with hSLO3 channels in heterologous
systems, and whether its presence would facilitate the expression of hSLO3
currents.
Co-expressing hLRRC52 with hSLO3 in Xenopus oocytes, I observed that
this is indeed the case. hSLO3 currents recorded from oocytes expressing both
hSLO3 and hLRRC52 are greatly increased compared to oocytes expressing
hSLO3 alone (Figure 34a). The currents recorded from hSLO3 + hLRRC52 most
likely originate from hSLO3 activity: these currents are blocked by the internal
application of Ba2+, a non-specific blocker of K+ channels, and furthermore no
currents can be observed when hLRRC52 is expressed on its own (data not
shown).
Co-expression with hLRRC52 modifies the functional properties of hSLO3
channels. First, the kinetics of channel opening is slowed down (see the different
time scales in Figure 34a). Second, the pH-dependence of hSLO3 + hLRRC52
currents is shifted to lower pH compared to hSLO3 expressed alone (Figure 34b).
The fact that LRRC52-co-expression has an activating effect on SLO3 channel at a
given pH has been described for the mouse mSLO3 homolog. Figure 34c shows
the results of co-expression of mSLO3 channels with the mouse mLRRC52
protein: pH activation is shifted to lower pH, but this activation effect is less
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Figure 34: Co-expression of SLO3 channels with LRRC52. 34a) Representative insideout patch currents recorded from Xenopus oocytes expressing either hSLO3 channels
alone or hSLO3 channels and hLRRC52 proteins. 34b-d) Effect of LRRC52 co-expression
on the pH dependence of hSLO3 and mSLO3 channels. Each figure illustrates a specific
combination of SLO3 and LRRC52 homologs: human SLO3 + human LRRC52 in 34b);
mouse SLO3 + mouse LRRC52 in 34c); human SLO3 + mouse SLO3 LRRC52 in 34d).
Errors bars, when shown, represent the standard errors from 3-5 independent
measurements. For the hSLO3/hLRRC52 and hSLO3/mLRRC52 co-expression, the
results shown are from a single experiment.
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pronounced than for the human hSLO3 channels. The precise effects of the
interaction between hSLO3 channels and LRRC52 require further analysis, which
is still under way. Nonetheless, the pH-dependence observed with the coexpression of SLO3 and LRRC52 is likely to reflect the pH sensitivity of the SLO3
channel itself. For example, the human and mouse homologs of LRRC52 affect
the pH-dependence of, respectively, hSLO3 and mSLO3 channels in a different
manner (Figures 34b-d). However, co-expressing hSLO3 with the mouse LRRC52
resembles the co-expression of hSLO3 with human LRCC52 (Figure 34d),
suggesting that the identity of the SLO3 channel, and not the LRRC52 protein,
defines the pH-dependence of the SLO3/LRRC52 complex.
Overall, hLRRC52 co-expression facilitates expression of pH-sensitive
hSLO3 channels. I believe I now have a robust system in hand in which I can
analyze the molecular basis of hSLO3 pH-gating using functional mutagenesis.
This paves the way for the direct comparison of the mechanism of pH sensing in
human vs. mouse SLO3 channels. At another level, the results presented here
describe for the first time that hLRRC52 might be an important physiological
partner of hSLO3 channels. Testing whether this is indeed the case in human
sperm cells would be very interesting.
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In conclusion, my studies of the structure of the human SLO3 gating ring
on the one hand, and of the mechanism of pH sensing of mouse SLO3 channels
on the other hand establish a first step towards understanding the molecular
basis of pH sensing in SLO3 channels. The fact that the mechanism of pH gating
seem not be conserved between the human and mouse homologs make a
definitive interpretation difficult, but I hope that mutagenesis studies on the
human SLO3 channel itself (using co-expression with LRRC52 proteins) will
allow us to decipher this difference.
Nonetheless, the structural and functional studies appear to agree on one
point: both suggest that, in SLO3 channels, conformational changes restricted to
the RCK1 N-lobe regions of the tetrameric gating ring might control pH-gating.
The significance of this hypothesis will be discussed in more details in the final
discussion chapter.
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CHAPTER FIVE: DISCUSSION

INTRACELLULAR GATING OF SLO CHANNELS
BY EUKARYOTIC GATING RINGS
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In the preceding chapters I have presented my Ph.D. work, part of a very
collaborative effort, that describes the crystal structures of the intracellular gating
modules from three eukaryotic SLO K+ channels: the monomeric structure of the
Ca2+-bound cytoplasmic domain (CTD) from the human SLO1 channel; the
tetrameric structure of the Ca2+-bound, open gating ring from the zebrafish SLO1
channel; and the tetrameric structure of the human SLO3 gating ring. These
structures, together with the Ca2+-free, closed SLO1 gating ring structure from
the Jiang laboratory, provide the molecular foundations to understand how
intracellular signals (Ca2+ binding in SLO1, Na+ binding in SLO2 or pH increase
in SLO3) control the opening of SLO channels. We now have in hand a precise
framework in which to interpret the vast array of functional analysis that has
been performed on these proteins over more than three decades. My own studies
on the mechanism of pH sensing in the mouse SLO3 channel are an illustrative
example in this respect.
In this final chapter, I will summarize my main results and examine them
in three different contexts. First, I will compare the similarities and differences
between the mechanisms of intracellular Ca2+ gating of the SLO1 and the
bacterial MthK channel. This is an interesting example of how, through
evolution, two proteins containing very similar domains can achieve the same
function (i.e., activation by intracellular Ca2+) using different strategies. This
example also highlights the functional and structural plasticity of the gating ring
scaffold. Second, I will come back to the comparison of hSLO3 gating ring with
the open conformation of the SLO1 gating ring and show how this comparison
could indicate convergent mechanistic principles in SLO1 and SLO3 channels.
Finally, I will look at how our structural studies suggest an added level of
complexity in the function of SLO channels in that the intracellular gating rings,
in addition to regulating the ion-conduction pore directly, may also modulate the
voltage sensor domains.
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5.1) Ca2+ sensing in SLO1 and MthK channels
The crystal structures of the SLO1 CTDs reveal for the first time the
precise molecular organization of the intracellular Ca2+-sensing apparatus in
SLO1 channels. The main conclusions of these studies are threefold. First,
individual SLO1 CTD subunits are formed by two tandem RCK domains (RCK1
and RCK2), whose architecture is closely related to the RCK domains found in
bacterial K+ channels. Second, the CTDs from each subunit of a tetrameric SLO1
channel assemble in a gating ring structure at the intracellular surface of the
membrane. In the tetrameric SLO1 gating ring, RCK1 domains from all four
subunits form a layer at the top, while RCK2 domains form a layer at the bottom.
The Ca2+ bowl in the SLO1 CTD is located on the side of the RCK2 domain and
creates four Ca2+ binding sites on the outer perimeter of the tetrameric gating
ring, at the interface between individual subunits. Third, Ca2+ binding in the
SLO1 gating ring induces a major conformational change in the upper layer of
RCK1 domains. This translates into an expansion of the gating ring diameter
(measured from the CTD N-terminal residues) that we can directly relate to the
opening of the transmembrane ion-conduction pore.
To date, the best-described example of an ion channel in which gating is
mediated by intracellular ligand binding in RCK domains is the bacterial Ca2+activated K+ channel MthK (122). As I presented in the introduction chapter,
MthK and related RCK-containing prokaryotic channels are believed to be
evolutionarily related to the eukaryotic SLO channels (24, 152), perhaps
representative of an ancestral K+ channel from which SLO1 evolved. In this
context, it is interesting to compare the structures and mechanisms of Ca2+
activation between SLO1 and MthK.
At first glance, the structures of the intracellular gating modules of SLO1
and MthK are highly similar. The bi-lobed architecture of individual RCK
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domains is strikingly conserved between the two channels: each RCK domain is
formed by a N-terminal lobe with a Rossman fold topology, followed by a helixturn-helix motif and a C-terminal lobe. In MthK, two separate identical RCK
domains (created by an alternative Met start site) dimerize through a large
“flexible interface” around their helix-turn-helix motifs in a similar manner than
RCK1 and RCK2 domains assemble in the SLO1 CTD. Four MthK RCK dimers
(equivalent to four CTD protomers in SLO1) assemble in a gating ring structure
in which the inter-subunit “assembly interfaces” involve the same secondary
structure elements as in the SLO1 gating ring (122). Finally, the open and closed
structures of the MthK gating ring (122, 155) reveal that channel opening is
triggered by an increase in diameter of the gating ring upon Ca2+ binding, like in
SLO1.
However, despite these structural resemblances, the actual mechanisms of
Ca2+ sensing in SLO1 and MthK channels are strikingly different. First of all, the
ligand binding site in SLO1 sits in a rather unexpected location based on the
expected properties of RCK domains. The α/β Rossman fold seen in RCK
domains is a very common structural motif found in enzymes or ligand binding
proteins, in which the active site or ligand binding site is located at the Cterminal end of the central β sheet (24, 204-206). RCK domains found in
prokaryotic channels or transporters are no exception to this rule, and examples
include Ca2+ binding in MthK (122) or nucleotide binding in the Trk/Ktr
transporter family (207, 208). Surprisingly, the Ca2+ binding site in the SLO1
RCK2 domain (the Ca2+ bowl) is not located at this preferred position but rather
sits on the side of RCK2. As a consequence, in the tetrameric context of the SLO1
gating ring, Ca2+ binds at the “assembly interface” between subunits, in marked
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contrast with MthK where the Ca2+ binding sites are located at the “flexible
interface” within single RCK dimers (Figure 35).
Another important difference between the Ca2+-binding CTDs from SLO1
and MthK lies in the symmetry (or lack thereof) of their structures. Again, the
MthK CTD “protomer” is an obligate dimer of identical RCK domains because
both RCK domains originate from the repeated translation of a single gene (122).
As a result, the MthK gating ring structure possesses, in addition to the global
four-fold symmetry axis of the channel, two additional two-fold symmetry axes
in the plane of the gating ring (colored green in Figure 35): the top and bottom
RCK layers in the MthK gating ring share the same architecture, and the whole
intracellular structure can be “flipped” upside-down (around one of the two-fold
axes) without consequence. On the other hand, the two RCK domains of a SLO1
subunit are separately encoded within the same gene (perhaps originally
through a gene duplication process), which allowed the RCK1 and RCK2
domains to evolve independently. The end result is that, in the SLO1 gating ring,
the top RCK1 layer is structurally different than the bottom RCK2 layer. This has
a direct consequence on the ligand-induced conformational changes observed in
the closed-to-open transition of the SLO1 and MthK gating rings. As I described
in Chapter 3, the conformational changes in the SLO1 gating ring are mostly
restricted to the upper RCK1 layer (Figure 24, see also the interpolative movie at
http://tinyurl.com/7zx3bwb). In contrast, in the MthK gating ring, the
conformational changes are the same in the top and bottom layers as imposed by
the added symmetry, and Ca2+ binding causes an expansion of the ring’s height
in addition to the dilation effect (155). The conformational changes between the
closed and open conformations of the MthK gating ring are best appreciated by
looking at an interpolative movie where the two conformations are morphed
(available at http://tinyurl.com/cwob2wp). Comparing the Ca2+-induced
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Figure 35: Comparison of the SLO1 and MthK gating ring structures. 35a) Cartoon
representation of the Ca2+ bound SLO1 gating ring. RCK1 and RCK2 domains are
colored blue and red, respectively. Ca2+ ions are shown as yellow spheres. 35b) Cartoon
representation of the Ca2+ bound MthK gating ring. RCK domains forming the top and
bottom layers of the structure are colored blue and red, respectively. Ca2+ ions are shown
as yellow spheres. In both 35a) and 35b), symmetry axes are shown in green in the right
panels (square: four-fold axis perpendicular to the plane of the figure, arrows: two-fold
axes in the plane of the figure).
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conformational changes between the MthK and SLO1 gating ring structures
highlights the profound mechanistic differences between these two related
proteins. Overall, this comparison presents an interesting example of how the
evolution of molecular structure within a class of proteins can give rise to
different mechanistic strategies to perform a similar function (i.e., triggering the
opening of the conduction pore of an ion channel upon Ca2+ binding).
At this point of the discussion, it is interesting to go back to the model I
put forward for the mechanism of pH sensing in the mouse mSLO3 channel. In
this model, which remains to be tested, the “pH sensor” in mSLO3 is located at
the flexible interface, between the bottom of the RCK1-N lobe and the RCK2
helix-turn-helix motif within the same mSLO3 subunit. Hence in mouse SLO3
channels (which are believed to have evolved from a SLO1 ancestor as the result
of a gene duplication event (209)), the pH sensor is located at a different interface
than the Ca2+ sensor in SLO1. This example, together with the comparison of
SLO1 and MthK, highlights the fact that gating ring scaffold capable of very high
functional and structural plasticity. The numerous interfaces existing in these
structures offer many opportunities for mechanistic remodeling, even between
closely related channels. This inherent plasticity might manifest itself most
dramatically in SLO3 channels. In the context of the rapid evolution of proteins
specialized in reproduction, it is perhaps not so surprising to observe that
mechanisms of pH sensing can be substantially remodeled between species
because the gating ring scaffold allows just that. There are probably multiple
ways to bias the conformation of a gating ring structure upon pH change,
especially since pH will affect the protonation state of many side chains in the
protein. Maybe during the rapid evolution of SLO3 channels, these different
possible mechanisms were extensively sampled.
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5.2) Comparing hSLO3 and SLO1 structures: functional implications
As I already presented in Chapter 4, comparing the structures of the
gating ring from the human SLO3 channel with the open or closed structure of
the SLO1 gating ring reveals interesting differences as well as, perhaps most
importantly, similitudes between these structures. In the hSLO3 gating ring
structure, the ring’s diameter matches almost perfectly the diameter of the open
SLO1 gating ring (94 Å vs. 93 Å, respectively, measured from the Cα position of
the N-terminal residues of two opposite subunits; the diameter of the closed
SLO1 gating ring is 81 Å). Moreover, the structure of the RCK1 N-lobes from all
four subunits in the hSLO3 gating ring matches closely the structure of the same
region in the open SLO1 gating ring, whereas the bottom RCK2 layers from the
same two structures do not align. If the hSLO3 gating ring is compared with the
closed conformation of the SLO1 gating ring, no significant similarity can be
detected between the two tetrameric structures. This led me to propose that the
human SLO3 gating ring structure represents the “open” conformation of the
hSLO3 intracellular pH-gating module.
I believe that the significant conservation of molecular architecture in the
RCK1 N-lobe layer between the gating rings of the hSLO3 and Ca2+-bound SLO1
channels reveals an interesting structural constraint. In a simple description of
SLO channel gating by intracellular signals, the gating ring can be viewed as a
module that simply transduces chemical energy (e.g., binding of Ca2+) into
mechanical work used to pull open the channel’s transmembrane helices. In this
context, only the overall diameter of the gating ring (measured at the N-terminal
positions connecting to the pore), but not the details of the gating ring structure,
determines channel opening. Considering the significant conservation of aminoacid sequence between SLO1 and SLO3 channels (in particular, the spring-like
transmembrane-to-CTD linkers have exactly the same length), it is perhaps not
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surprising that the gating rings from both channels would reach equivalent
diameters in the open state. But in the context of the high structural plasticity of
the gating ring scaffold, and keeping in mind the rapid evolution of SLO3
channels, it is not hard to imagine that a completely different architecture could
have evolved in SLO3 channels that would preserve the same overall diameter as
in SLO1, but not the actual structure of the RCK1 layer of the gating ring. Then, if
the hSLO3 structure really does represent the open conformation of the hSLO3
gating ring, what could explain the structural conservation we observe in the
RCK1 N-lobe layer? I can mostly think of two (non-exclusive) possibilities. The
first possibility would be that the RCK1 N-lobe layer, being the “active” region of
the gating ring that rearranges during intracellular activation, is structurally
constrained in the same way that the geometry of the active site (but not
necessarily the rest of the structure) is conserved within a class of enzymes. Once
an efficient molecular solution (in our case, a specific rearrangement of the RCK1
N-lobe layer) exists to perform a given function (in our case, opening the channel
pore), the same solution is conserved during evolution. A correlate of this
hypothesis would be that, in the closed state of the hSLO3 gating ring, the
architecture of the RCK1 N-lobe layer would match the closed conformation of
the SLO1 gating ring. The second explanation would be that, in SLO channels,
the RCK1 N-lobe region interacts with other parts of the protein, and that this
interaction constrains structurally the position of the RCK1 N-lobes. It is possible,
as I will discuss in the next section of this chapter, that a significant molecular
interface exists between the RCK1 N-lobe layer and the transmembrane domain
of a SLO channel. In this case, the conserved architecture of the SLO1 and SLO3
transmembrane domains (expected based on sequence homology) would
constrain the actual position of the RCK1 N-lobes between SLO1 and SLO3
channels in a similar manner.
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5.3) A possible interface between eukaryotic gating rings and voltage-sensing
domains
With the structures of the gating ring we now have in hand, it becomes
possible to estimate what the structure of a full SLO channel might look like. I
created models of a full SLO1 channel with an open or closed gating ring by
using the same models used in Figure 26 (page 80) and replacing the ion
conduction pores by the transmembrane domain of the paddle chimera voltagedependent KV channel (141) by aligning the invariant selectivity filters. The
result is shown in Figure 36. In both the open and closed conformation, the SLO1
gating ring appears to fit well against the surface of the transmembrane KV
domain, with ridges from the gating ring fitting naturally into grooves that exist
between the voltage sensors and the pore. Interestingly, the part of the SLO1
gating ring coming in close contact with the transmembrane domain in these
models is precisely the βA-βC region of the RCK1 N-lobe, i.e. the part whose
structure changes the most dramatically in the close-to-open transition of the
SLO1 gating ring (Figure 36, recall also Figure 24 page 76). This raises the
possibility that interactions with the transmembrane domain might functionally
regulate the movement of the RCK1 βA-βC regions in the channel, and therefore
influence intracellular gating. Importantly, previous experiments support the
idea of a structural connection between the gating ring and the transmembrane
domains of the SLO1 channel. In particular, functional studies have identified a
putative Mg2+ binding site bridging two Glu residues located in the βA-βC region
of the RCK1 N-lobe to amino acids on the voltage sensor (210, 211).
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Figure 36: Models of the SLO1 channel. Cartoon representation of the molecular
models of the SLO1 channel obtained by docking the transmembrane domain of the KV
chimera channel (PDB ID 2R9R) onto the models shown in Figure 26 (page 80). Models
obtained using the open and closed conformation of the SLO1 gating ring are shown on
the left and right panels, respectively. Voltage-sensor domains (VSD) are colored orange,
pore domains are colored green and RCK1 and RCK2 domains are colored blue and red,
respectively. In the side view (bottom panels), all domains at the front and the back are
removed for clarity.
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Overall, this very simple modeling exercise suggests that, in eukaryotic
SLO channels, the interface between the gating ring and the voltage sensor
domains could be larger than previously appreciated. A direct physical
interaction between these two gating modules would allow the two synergistic
signals required for channel activation (membrane voltage and intracellular cue)
to modulate each other. Only the structure of an entire SLO channel would
directly address this hypothesis. Considering the progress we made for the
recombinant expression and purification of SLO channels in Sf9 cells (presented
in Chapter 2), I am confident that the long-awaited crystal structure of a SLO
channel is forthcoming. I have no doubt that such structure would reveal an
unprecedented level of complexity that would be fascinating to decipher in terms
of functional mechanisms.
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MATERIALS AND METHODS

1) SLO constructs expression and purification

Protein expression in Pichia yeast
Protein constructs (described below in the relevant sections) were sub-cloned in
the PICZ-c vector (Invitrogen). Pichia pastoris cells (HIS+ strain of SMD1163,
Invitrogen) were transformed by electroporation (BioRad Micropulser) using
vector linearized with PmeI as described in the manufacturer’s manual.
Transformants were selected on YPDS plates (Invitrogen) containing 400-1200
µg/ml Zeocin (Invitrogen), and used to inoculate small-scale cultures in BMGY
medium (Invitrogen) grown at 30°C overnight. For large-scale expression, 1-L
cultures in BMGY medium were inoculated using the small-scale cultures and
cells were grown at 30°C until OD600 reached ~20. Cells were then pelleted,
resuspended in BMM medium (Invitrogen) and expressed overnight at 30°C.
Cells were harvested by centrifugation, flash-frozen in liquid N2 and stored at 80°C.

Protein expression in Sf9 cells
Protein constructs were sub-cloned in the pFastBac vector (Invitrogen) and
baculovirus was generated using the Bac-to-Bac system (Invitrogen) following
the instructions manual. Sf9 cells were cultured at 27°C in supplemented Grace’s
insect cell medium (Invitrogen) to a density of ~ 1.0 106/mL before infection with
baculovirus. Infected cells were cultured for ~60 hours at 27°C, then harvested by
centrifugation and washed in ice-cold PBS. Cell pellets were flash-frozen in
liquid N2 and stored at -80°C.
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Protein expression in HEK cells
Protein constructs were sub-cloned in the pCGFP-EU vector (175). HEK cells
were grown in 6-well plates in DMEM medium (Invitrogen) in a 37°C incubator.
HEK cells reaching ~90% confluence were transfected using lipid-mediated
transfection (Lipofetamine 2000, Invitrogen). Transfected cells were used 48h
thereafter.

Protein constructs
The following genes where used as template for subcloning: human SLO1
HsloM3 (GI: 507922, a gift from L. Toro); Aplysia californica SLO1 (GI: 39545756, a
gift from L. Kaczmarek); rat SLO2.2 (GI: 11177892, a gift from L. Kaczmarek);
mouse SLO3 (GI: 86646081, a gift from L. Salkoff); human SLO3 (GI:157074213),
chicken SLO2.2 (GI: 20338417) and zebrafish SLO1 (GI: 189526846) genes were
identified in database searches and were synthetized by Bio Basics, Inc. For
recombinant expression, constructs of interest were fused to a C-terminal GFP
followed by a deca-histidine affinity tag (GFP-His10) or a 1D4 tag (GFP-1D4,
amino-acid sequence for 1D4: TETSQVAPA). A PreScission protease (GE
Healthcare) cleavage site (LEVLFQG) was introduced before the C-terminal GFP.
The PreScission recognition sequence and a cloning site (EcoRI) result in a stretch
of amino acids SNSLEVLFQ attached to the C-terminus of all constructs. CTD
constructs of human hSLO1, chicken gSLO2.2, zebrafish zSLO1 and human
hSLO3 were expressed as GFP-His10 fusions in Sf9 cells included the following
amino acids: for hSLO1, residues 341-1056; for gSLO2.2, residues 347-1201, for
zSLO1, residues 341–1060 with a loop deletion (839–872); for hSLO3, residues
330-1041 with a loop deletion (831-852).
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Fluorescence size-exclusion chromatography
Small-scale cultures of Pichia, Sf9 or HEK were lysed in a buffer containing (in
mM): 150 KCl (unless stated otherwise), 50 TRIS pH 8.0; 1 EDTA; 40 DDM; 10
dithiothreitol (DTT) containing protease inhibitor cocktail IV (EMD Biosciences).
Size-exclusion chromatography on a Superose-6 column (GE Healthcare) was
carried out in buffer containing (in mM): 150 KCl, 20 TRIS pH 8.0; 1 EDTA; 1
DDM; 10 DTT. GFP fluorescence was monitored using a Shimadzu RF-10AXL
detector.

Cell lysis
The following lysis methods were used: frozen Pichia cells were lysed in a Retsch,
Inc. Model MM301 mixer mill (5 x 3.0 min. at 25 cps), keeping the grinding jars in
liquid N2 between milling cycles. Sf9 cells were disrupted by sonication on ice.
HEK cells were lysed by resuspension in detergent-containing buffer (typically
40 mM DDM). The following cocktail of protease inhibitors was used for all
large-scale purification protocols described here: 3 µg/ml aprotinin, 2 mM
benzamidine, 5 µg/ml leupeptin, 2 µg/ml pepstatin A, 200 µg/ml 4-(2Aminoethyl)

benzenesulfonyl

fluoride

hydrochloride,

and

250

µM

phenylmethane sulphonylfluoride (Sigma-Aldrich). Deoxyribonuclease (DNase)
1 (Worthington) was also included in all lysis buffers.

Purification of detergent-solubilized SLO1 channels
Pichia or Sf9 cells expressing human or Aplysia SLO1 GFP-1D4 constructs were
lysed at 4°C in buffer containing: 150 mM KCl; 50 mM HEPES KOH; 50 mM
DDM or DM; final pH 8.0, containing DNase and protease inhibitors. Lysate was
incubated for 3 hours at 4°C to allow membrane protein extraction, then clarified
by centrifugation (30,000xg, 45’, 4°C). Supernatant was added to 1D4-affinity
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resin pre-equilibrated in 150 mM KCl, 10 mM HEPES KOH, 4 mM DM, final pH:
7.4. Suspension was layered with argon gas and incubated overnight at 4°C,
mixing by gentle inversion. Resin was collected on a column by gravity, washed
with 2 column volumes (CV) of buffer (150 mM KCl, 10 mM HEPES KOH, 4 mM
DM, final pH: 7.4, flow rate 0.2 mL/min), and eluted in buffer supplemented
with 1 mg/ml 1D4 peptide (AnaSpec, Inc.) over 1 hour at room temperature. 10
mM DTT and PreScission protease (1:40 w/w) were added to the eluted protein.
Protease cleavage was carried out for 4 hours at 4°C, after which the protein was
concentrated and further purified by gel filtration at 4°C on a Superose-6 column
in buffer containing: 150 mM KCl; 20 mM HEPES KOH; 6 mM DM 10 mM DTT;
final pH: 7.4. The fraction corresponding to the tetramer peak was isolated and
concentrated to ~1-5 mg/mL.

Purification of CTD constructs
CTD constructs of human hSLO1, chicken gSLO2.2, zebrafish zSLO1 and human
hSLO3 were expressed as GFP-His10 fusions in Sf9 cells. The following buffers
were used during cell lysis at 4°C. For hSLO1, gSLO2.2 and zSLO1 (in mM): 300
NaCl, 50 HEPES pH 8.0, 10 imidazole, and 5 β-mercaptoethanol (β−ΜΕ),
containing DNase and protease inhibitors. For hSLO3 (in mM): 500 KCl; 50 Kphosphate; 10 imidazole and 5 β−ΜΕ, final pH 8.0, containing DNase and
protease inhibitors. The cell lysate was clarified by ultracentrifugation
(250,000xg, 80’, 4°C). Supernatant was applied by gravity onto TALON metal
affinity resin (Clontech) pre-equilibrated in lysis buffer, at 4°C. The resin was
then washed with 10 column volumes of lysis buffer supplemented with extra 10
mM imidazole and eluted in lysis buffer supplemented with extra 290 mM
imidazole (all steps at 4°C). 10 mM DTT and PreScission protease (1:40 w/w)
were added to the eluted protein. Protease cleavage was carried out overnight at
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4°C, after which the protein was concentrated and further purified by gel
filtration at 4°C on a Superose-6 column. The following gel filtration buffers were
used. For hSLO1 (in mM): 150 NaCl, 20 TRIS pH 8.0, 50 CaCl2, 20 DTT, and 1.5
TRIS(2-carboxyethyl)phosphine (TCEP). For gSLO2.2 (in mM): 500 NaCl, 20 TRIS
pH 8.0, 20 DTT, and 1.5 TCEP. For zSLO1 (in mM): 150 NaCl, 20 HEPES pH 8.0,
20 DTT. For hSLO3 (in mM): 500 KCl, 20 K-phosphate, 20 DTT, 1.5 TCEP, final
pH 8.5. For crystallization experiments, all proteins were concentrated to 5-6
mg/mL. For the zSLO1 CTD, 10 mM CaCl2 was added to the protein before
crystallization.

2) IbTx binding studies

Recombinant IbTx expression and purification
Recombinant iberiotoxin (IbTx) expression in E. coli was based on protocols
originally described for charybdotoxin (188, 212), with minor modifications. IbTx
was expressed in E. coli BL21(DE3) cells as a fusion construct containing the T7
gene 9 sequence and a factor Xa cleavage site before the toxin N-terminus. Largescale bacterial cultures were grown in standard LB medium at 37°C and protein
expression was induced when OD600 reached 0.9 using 0.5 mM IPTG. Induction
was carried out for 2.5 hours, after which the cells were pelleted and flash-frozen
in liquid N2. Cells were resuspended in ice-cold lysis buffer (in mM): 50 NaCl, 10
TRIS pH 8.0, 2 EDTA, 7 β−ME, containing DNase and protease inhibitors.
Mechanical lysis was performed using a French press. The lysate was clarified by
centrifugation (30,000xg, 45’, 4°C), after which DNA was precipitated using 30%
w/v streptomycin sulfate, stirring for 10’ on ice. The solution was spun down
(30,000xg, 20’, 4°C), and solid ammonium sulfate was slowly added to the
supernatant (31 g ammonium sulfate per 100 mL of supernatant, i.e. 50%
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saturation). Ammonium sulfate precipitation was carried on overnight at 4°C
under gentle stirring. The precipitate was collected by centrifugation (30,000xg,
20’, 4°C) and the pellet dissolved in 50 mM NaCl, 50 mM TRIS pH 7.0, 5 mM βME. The T7 gene 9-IbTx fusion was then purified by ion-exchange
chromatography on a DE-52 column at 4°C (salt gradient: 50 to 500 mM NaCl in
50 mM TRIS pH 7.0, 5 mM β-ME). Fractions containing the fusion protein were
dialyzed against 100 mM NaCl, 20 mM HEPES pH 8.0, 1 mM β-ME for 3 days at
4°C. After diluting the dialyzed protein solution to A280 = 2.0 (in dialysis buffer),
1 mM CaCl2 was added and the fusion protein was cleaved using 10 µg/mL
trypsin (45’ at room temperature (RT), stirring). IbTx was isolated using ionexchange chromatography on a mono-S column (salt gradient: 10-1000 mM NaCl
in 10 mM HEPES, pH 8.0). The main fraction (pure IbTx) was isolated and
supplemented with 5% v/v acetic acid, then incubated for 4 hours at 65°C for
cyclization of the N-terminal glutamine. IbTx was then further purified by HPLC
on a C18 column, using a 10-45 % gradient (buffer A: 0.1 % trifluoroacetic acid
(TFA) in H2O; buffer B: 0.1 % TFA in 9:1 acetonitrile:H2O). The purified IbTx was
collected and lyophilized, and its mass confirmed by mass spectrometry.
For the purification of the IbTx-D19C mutant, the same protocol was followed
except that a glutathione adduct was formed after trypsin cleavage by the
sequential addition of 0.5 mM DTT (30’ at RT, stirring) and oxidized glutathione
(1h at RT, stirring).

IbTx resin generation
The gluthatione-protected IbTx-D19C mutant was reacted with 10 mM DTT in 50
mM Na-phosphate pH 7.0 (30’ at RT), and the reduced toxin was purified by
HPLC as described above. The IbTx-D19C fraction was lyophilized in a vacuum
concentrator and dissolved in coupling buffer (50 mM TRIS pH 8.2, 5 mM Na	
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EDTA), then incubated at RT for 30 minutes. The toxin was then coupled to
SulfoLink resin (Pierce) using the free sulfhydryl group of the introduced Cys19
(5 hours at RT with gentle stirring). Any unreacted iodoacetamide groups on the
resin were then capped by treatment of the resin with 1% β-ME in coupling
buffer for 1 h at RT. Following the capping reaction, the resin was extensively
washed in coupling buffer, and stored at 4°C as 50 % slurry in 50 mM NaCl, 10
mM Na-phosphate pH 7.0, 0.05 % Na-azide. A control resin “mock” resin was
also produced in which the iodoacetamide groups were simply capped with 1%
β-ME.

IbTx labeling
The IbTx-D19C mutant was labeled using maleimide derivatives by reaction onto
the sulfhydryl group of the introduced Cys19 using protocols previously
described for ChTx (188). Briefly, IbTx-D19C was deprotected and HPLC
purified as described above. The deprotected toxin was then reacted using slight
excess (1.1 x) of NEM derivatives in 50 mM NaCl, 50 mM Na-phosphate pH 7.0.
The reaction was carried out for 15 minutes at room temperature, after which the
labeled IbTx was purified by HPLC as described above. Two maleimide
derivatives were used: the fluorescent tetramethylrhodamine-5-maleimide
(Molecular Probes) and the radioactive 14C-N-ethylmaleimide (Perkin Elmer). For
the reaction with 14C-N-ethylmaleimide, two diastereomers were obtained and
both forms were used. Masses of the labeled compounds were confirmed by
mass spectrometry. To measure the specific activity of

14

C-IbTx, toxin

concentration was determined using absorbance at 280 nm and the theortical
extinction coefficient predicted on the basis of the amino-acid sequence: ε = 7400
M-1 cm-1. The measured specific activity was 31.5 ±0.3 Ci/mol.
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IbTx pull-down assays and 14C-IbTx binding assays
To avoid the use of reducing agents during the IbTx binding assays on
solubilized SLO1 channels, 5 mM iodoacetamide was added at the beginning of
cell lysis during SLO1 purification to cap endogenous cysteines. Then, reducing
agents were omitted during all the steps of channel purification described above.
Pull-down assays were typically performed in assay buffer containing 150 KCl
(unless stated otherwise), 50 HEPES pH 8.0 and 3 mM DM. 150 µL of solution
containing solubilized SLO1 channel was incubated with 20 µL of IbTx-resin (40
µL of 50 % slurry) and binding was carried out at room temperature for 90
minutes under gentle mixing. The beads were then washed extensively in icecold assay buffer (using sequential centrifugation steps). Resin-bound channels
were eluted by boiling the resin in 1x SDS-sample buffer before SDS-PAGE
analysis.
14

C-IbTx binding assays were performed following previously described

protocols (182, 183), with a few modifications. SLO1 channels were purified in
binding buffer containing 150 mM KCl, 20 mM HEPES pH 7.4, 50 mM CaCl2 and
6 mM DM. Binding reaction were set up in a total volume of 100 µL by mixing
100 nM receptor (i.e., tetrameric channel) with 10-1000 nM

14

C-IbTx and

incubating the reaction for 1 hour at RT with gentle shaking. Channel-toxin
complexes were recovered on G4 glass filters (Whatman) pre-incubated in 0.5 %
polyethyleneimine (in H2O). The filters were washed extensively in ice-cold
buffer (150 mM KCl, 20 mM HEPES pH 7.4) using a vacuum filtering system. The
washed filters were finally counted for 14C radiation by scintillation. Non-specific
binding was determined from control samples containing a large excess (> 60 x)
of unlabeled IbTx.
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3) Crystallization and structure determination

Monomeric Ca2+-bound hSLO1 CTD structure and gSLO2.2 crystals
The hSLO1 CTD was crystallized at 20°C by hanging-drop vapor diffusion
against reservoir solution containing 50 mM TRIS, 9-12% (v:v) PEG 400, and 100
mM potassium phosphate (pH 8.0). Tetragonal crystals belonging to space group
I422 grew to full size within a week and were cryoprotected by increasing the
concentration of PEG 400 to 30% in the reservoir solution supplemented with 500
mM NaCl. Diffraction data for native crystals of human SLO1 CTD were
measured at the Advanced Photon Source beamline 24 ID-C. Diffraction data for
selenomethionine-substituted crystals of the hSLO1 CTD and the gSLO2.2 CTD
crystals were collected at beamline X29 from the National Synchrotron Light
Source. All diffraction images were processed with the HKL2000 program suite
(213).

Initial

MAD

phasing

for

hSLO1

CTD

was

calculated

using

SOLVE/RESOLVE (214). Thirteen selenium sites were found and the solventflattened electron density map at 3.3 Å resolution was of high quality. The
protein chain was readily traceable and iterative model building was carried out
in COOT (215). Rounds of refinement were performed with REFMAC. The final
model was refined to 3.0 Å resolution with Rwork = 0.246 and Rfree = 0.278. A few
disordered loop regions were not built due to poor electron density and the final
refined model includes residues 343-570, 577-613, 677-806, 817-833, 869-945, 9491020, and 1025-1056. All side chains but two (L353 and W477) were modeled. The
majority (94.6%) of the residues lie in the most favored region in a
Ramachandran plot (216), with the remaining 5.4% in the additionally allowed
regions. One Ca2+ ion and one SO42- were modeled in the structure. For molecular
replacement, a poly-alanine model for the refined SLO1 CTD structure was used
as the search model against the 6.0 Å diffraction data from the gSLO2.2 CTD. A
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unique solution with a standout Z-score was identified using the program
PHASER (1). Data collection and structure refinement statistics are shown in
Table 1. All structural illustrations and electron density maps were prepared
with PYMOL (www.pymol.org).

Open structure of the zSLO1 gating ring
Crystals of the zebrafish SLO1 CTD were grown at 20°C using hanging-drop
vapor diffusion by mixing equal volumes of protein and a reservoir solution
containing 50 mM 2-(N-morpholino)ethanesulfonic acid (MES), 4% (w/v) PEG
4000 and 100 mM potassium sodium tartrate (pH 6.3). The crystals grew to a
maximum size of about 0.2 mm x 0.2 mm x 0.3 mm within three days. Before
being flash frozen in liquid nitrogen, the crystals were briefly transferred to a
cryoprotectant solution containing 50 mM MES, 6% (w/v) PEG 4000, 100mM
potassium sodium tartrate, 150mM NaCl, 10 mM CaCl2 and 30% ethylene glycol
(pH 6.3). The crystals belong to space group P212121 and the unit cell has
dimensions of a = 137.65 Å, b = 210.82 Å and c = 238.76 Å with α = β = γ = 90°.
Each asymmetric unit contains eight protein subunits.
Diffraction data were measured at beamline X29 of the National Synchrotron
Light Source and were processed with the HKL2000 program suite (1). The
scaled data set was anisotropically corrected to resolution limits of 4.0, 3.6 and
3.6 Å along the reciprocal cell directions a*, b*, and c*, respectively, using the
diffraction anisotropy server at the University of California, Los Angeles (200).
An isotropic B factor of 229.98 Å2 was applied to restore the magnitude of the
high-resolution reflections diminished by anisotropic scaling. The structure was
determined by molecular replacement using the monomeric Ca2+-bound human
SLO1 CTD (PDB ID 3MT5) as the search model. Initial phases were improved by
eight-fold non-crystallographic symmetry averaging carried out with DM from
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the CCP4 program suite (217). Iterative model building was carried out in COOT
(1). Rounds of refinement were performed with CNS (218) and REFMAC (219),
and strong eight-fold non-crystallographic symmetry restraints were maintained
throughout refinement. The final model was refined to a resolution of 3.6 Å with
Rwork = 0.260 and Rfree = 0.289. A few disordered regions were not modeled owing
to weak electron density, and the final refined model includes residues 343–571,
581–614, 688–810, 817–837, 875–949, 953–1,024 and 1,029–1,059. Residues for
which side-chain density was poorly defined were modeled as alanines. The
majority (95.9%) of the residues lie in the most favored region in a
Ramachandran plot, with the remaining 4.1% in the additionally allowed
regions. Eight Ca2+ ions were modeled in the Ca2+ bowls from the two gating
rings in the crystal. Data collection and structure refinement statistics are shown
in

Table

2.

All

structural

illustrations

were

prepared

with

PYMOL

(www.pymol.org). The multiple-chain morphing script for CNS (220) was used
to generate coordinates for the movies described in Chapter 3.

hSLO3 gating ring structure
Crystals of the human SLO3 CTD were grown at 20°C using hanging-drop vapor
diffusion by mixing equal volumes of protein and a reservoir solution containing
50 mM K-phosphate, 3% (w/v) PEG12000 and 1 M ammonium formate (final
pH: 6.3). The pH of the final solution obtained by mixing equal amounts of
protein and reservoir solutions was measured to be 6.8. The crystals grew to a
maximum size of about 0.4 mm x 0.15 mm x 0.05 mm within three days. Crystals
were sequentially transferred into cryoprotective solutions (all containing 500
mM KCl, 70 mM K-phosphate, 4% (w/v) PEG12000, 1 M ammonium formate,
final pH 6.4) containing increasing concentrations of ethylene glycol (5%, 10%,
20%, final ethylene glycol concentration of 30 % (w/v)) before being flash-frozen
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in liquid N2. The crystals belong to space group I222 and the unit cell has
dimensions of a = 124.54 Å, b = 157.94 Å and c = 249.01 Å with α = β = γ = 90°.
Each asymmetric unit contains two CTD subunits.
Diffraction data were measured at beamline X29 of the National Synchrotron
Light Source and were processed with the HKL2000 program suite (213).
Diffraction of X-rays by these crystals was very anisotropic, and analysis
revealed that diffraction in the a* and b* directions of the reciprocal cell are the
weakest. In the final dataset used for structure determination, diffraction data
collected from two independent crystals that varied in their degree of diffraction
anisotropy were merged. These reflections were scaled together in SCALEPACK
(213) to produce a unique, final dataset. The scaled data set was anisotropically
corrected to resolution limits of 3.8, 3.4 and 3.3 Å along the reciprocal cell
directions a*, b*, and c*, respectively, using the diffraction anisotropy server at
the University of California, Los Angeles (200). An isotropic B factor of 105.89 Å2
was applied to restore the magnitude of the high-resolution reflections
diminished by anisotropic scaling. The structure was determined by molecular
replacement using the monomeric Ca2+-bound human SLO1 CTD (PDB ID 3MT5)
as the search model. Structure refinement was carried out in REFMAC (219)
using strong two-fold non-crystallographic symmetry restraints. Iterative model
building was carried out in COOT (215). The final model was refined to a
resolution of 3.4 Å with Rwork = 0.248 and Rfree = 0.268. A few disordered regions
were not modeled owing to weak electron density, and the final refined model
includes residues 332–353, 362–371, 378–559, 567–601, 681–702, 706–806, 812-829,
858-932, 952-970, 981-1007, 1014-1040 and 1,029–1,059. Residues for which sidechain density was poorly defined were modeled as alanines. The majority
(93.0%) of the residues lie in the most favored region in a Ramachandran plot,
with the remaining 7% in the additionally allowed regions. Data collection and
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structure refinement statistics are shown in Table 3. All structural illustrations
were prepared with PYMOL (www.pymol.org).

4) Electrophysiology

Purified SLO1 channel reconstitution
Channel reconstitution was done following the procedure described in (221).
Lipids (1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine:	
   1-Palmitoyl-2oleoyl-sn-glycero-3-phosphoglycerol, i.e. POPE:POPG, 3:1 w/w) in chloroform
were transferred with a glass syringe into a glass test tube, dried with an argon
stream, washed with pentane, and then placed under room vacuum for 30
minutes. Dried lipids were then hydrated with dialysis buffer containing 450
mM KCl and 10 mM HEPES-KOH pH 7.4 at a lipid concentration of 10 mg/ml.
The lipid suspension was vortexed briefly and sonicated 5-10 times (30 second
each) to produce small unilamellar vesicles. DM was added into the vesicle
suspension to a final concentration of 10 mM. The mixture was rotated for 30
minutes at room temperature and then solubilized SLO1 protein was added to
the lipid/detergent mixture to a protein-to-lipid ratio (w/w) ranging from 0.1 to
1.0. Detergent concentration was then raised to 17.5 mM. The mixture was
incubated for two hours at room temperature and then dialyzed against the
dialysis buffer at 4°C. The buffer was changed every 12 hours. After three days
the vesicles were collected, flash-frozen with liquid nitrogen, and stored at
−80°C.

Bilayer recordings
The bilayer experiments followed published procedures (221, 222). Lipids
(POPE:POPG 3:1 w/w) were dried under argon and dissolved in decane, then
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were painted over a 300 µm hole in a polystyrene partition that separated two
aqueous chambers. Once formation and thinning of a planar lipid membrane was
detected through monitoring of the electrical capacitance, lipid vesicles were
delivered to the membrane surface with a pipette. Vesicle fusion was facilitated
by the presence of a salt gradient across the membrane: 15 mM KCl on the side
opposite vesicle addition (trans side) and 150 mM KCl on the side of vesicle
addition (cis side). Both sides were buffered with 10 mM HEPES-KOH at pH 7.4.
After vesicle fusion, the salt concentration on the trans side was raised to 150
mM.

Patch-clamp electrophysiology
Full length hSLO3 channel was cloned into the pGEM-HE vector (223). The
constructs of mSLO3 in pOX (94) and of human and mouse LRRC52 in pXMX
were generous gifts from L. Salkoff and C. Lingle, respectively. Plasmids were
linearized and capped cRNA was produced by in vitro transcription using the
mMessage mMachine reagents (Invitrogen). cRNA was purified using
phenol/chloroform extraction and ethanol purification, and stored at -80°C.
Oocytes were dissected from anesthetized Xenopus leavis (African clawed frogs)
by a survival surgery. Oocytes were immediately treated with collagenase (2
mg/mL) for 1.5 hours, rinsed with a Ca2+-free OR-2 solution (82.5 mM NaCl, 2.5
mM KCl, 1 mM MgCl2, 5 mM HEPES pH 7.6) and stored in ND-96 solution (96
mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM HEPES pH 7.6)
containing fresh gentamycin (50 mg/L). Within 2 days of dissection, oocytes
were injected with ~10 ng of purified RNA. For SLO3/LRRC52 co-expression
studies, the two constructs were injected in a 1:1 w/w ratio. Electrophysiological
measurements were made 3-6 days after injection. Oocytes were incubated at
18°C.
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For recording, inside-out patches were excised from freshly devitellinized
oocytes using fire-polished glass pipettes with a typical resistance of 0.8-1.2 MΩ.
Large pipettes were used in order to increase the amplitude of SLO3 current in a
patch. Axopatch amplifier 200B (Axon Instruments), a digitizer (Axon
Instruments DigiData 1440A) and Clampex 10.2 software (Axon Instruments)
were used in the recording of data. Patches were excised in an inside-out
configuration, exposing the intracellular face of membrane and embedded
channels to a bath solution controlled by a custom-built gravity-flow perfusion
system. Pipette solution contained (in mM): 140 K-gluconate, 20 HEPES, 2 MgCl2,
with pH adjusted to 7.0. Bath solutions contained (in mM): 140 K-gluconate, 20
HEPES, 5 EGTA (acid form), and pH was carefully adjusted with KOH to the
desired value. During recording, the membrane voltage was held at -60 mV and
currents were elicited by pulsing the voltage from -140 to +180mV in 20-mV
increments.
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TABLES
Table 1: Summary of crystallography data for the monomeric Ca2+-bound
!

hSLO1 CTD structure presented in Chapter 3
Datasets

Native

Selenium

gslo2.2 CTD

Resolution (Å)

3.0

3.3

6.0

Space Group

P6322

P6322

I422

Source
Cell Constants
a, b, c (Å)
a, b, g( (°))

APS 24ID-C

BNL X29

BNL X29

a = b = 144.5
c = 182.2
90, 90, 120

a = b = 145.1
c = 182.4
90, 90, 120

a = b = 126.3
c = 239.0
90, 90, 90

Peak

Inflection

Remote

Wavelength (Å)

0.9792

0.9792

0.9793

0.9640

1.0750

Completeness (%)

99.9 (99.9)

99.8 (100)

99.8 (100)

99.8 (100)

95.3 (96.7)

Rmerge

0.089 (0.738)

0.105 (0.493)

0.100 (0.533)

0.130 (0.745)

0.108 (0.746)

Reflections

23149

17611

17641

17649

2520

I/!

19.6 (2.4)

18.8 (3.3)

18.2 (3.1)

13.9 (2.2)

21.4 (3.1)

Redundancy

5.8 (5.9)

7.0 (7.2)

7.0 (7.2)

7.0 (7.2)

9.1 (9.6)

MAD Phasing (SOLVE/RESOLVE)
Number of sites

13

Resolution (Å)

3.3

Overall Figure of Merit

0.70

Refinement
Resolution (Å)

50 - 3.0

Rwork

0.249 (0.327)

Rfree

0.282 (0.324)

Number of atoms
Protein

4692
2+

Ligand (Ca )

1
2

Average B factors (Å )

67.1

Ramachandron plot
Favored (%)

94.3

Allowed (%)

5.7

Disallowed (%)

0

RMSD Bond lengths(Å)

0.010

RMSD Bond angles (°)
1.214
Rfree was calculated with 5% of the data.
Numbers in parentheses represent values in the highest-resolution shell.
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Table 2: Summary of crystallography data for the Ca2+-bound zSLO1 gating
ring structure presented in Chapter 3

Zebrafish SLO1 CTD
Data collection
Resolution (Å)

3.6

Space group

P212121

Source
Cell dimensions: a, b, c (Å)
!, ", #( (°))
Wavelength (Å)

BNL X29
137.65, 210.82, 238.76
90, 90, 90
1.075

Completeness (%)

99.4 (99.5)

Rmerge

0.103 (0.794)

I/$I

11.9 (1.5)

Redundancy

4.2 (4.2)

Refinement
Resolution (Å)
Low
High (a*, b*, c*)a
No. of reflections (total / test)

48
4.0, 3.6, 3.6
71878 / 3620

Completeness (%)b

93.8 (30.9)

Rwork

0.283 (0.386)

Rfree

0.293 (0.391)

Number of atoms
Protein

37304
2+

Ligands (Ca )

8
2

Average B factors (Å )

99.3

Ramachandron plot
Favored (%)

95.9

Allowed (%)

4.1

Disallowed (%)

0

RMSD Bond lengths (Å)

0.007

RMSD Bond angles (°)

1.138

Rfree was calculated with ~5% of the data.
Numbers in parentheses represent values in the highest-resolution shell.
a
Reflections beyond these limits were excluded from refinement after
anisotropic correction (a*, b*, and c* indicate reciprocal cell directions).
b
Completeness after anisotropic correction.
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Table 3: Summary of crystallography data for the hSLO3 gating ring structure
presented in Chapter 4
Datasets

Dataset #1

Dataset #2

Resolution (Å)

3.3

3.4

Merged
dataset
3.3

Space Group

I222

I222

I222

Source
Cell Constants
a, b, c (Å)
!, ", #( (°))
Wavelength (Å)

BNL X29
a = 124.10
b= 158.90
c = 248.27
90, 90, 90
1.075

BNL X29
a = 124.53
b= 157.94
c = 249.00
90, 90, 90
1.29

a = 124.54
b = 157.94
c = 249.00
90, 90, 90

Completeness (%)

99.6 (100)

99.7 (100)

99.9 (100)

Rmerge

0.081 (0.810)

0.095 (0.957)

0.124 (>1)

Reflections

23149

17611

2520

I/$

15.9 (1.6)

12.5 (1.3)

15.0 (1.8)

Redundancy

4.8 (4.8)

3.5 (3.4)

8.3 (8.3)

Refinement (using anisotropic correction)
Resolution (Å)
Completenessb
Rwork

50 - 3.4 (a*, b*, c*: 3.8, 3.4, 3.4)a
90.0 (38.6)
0.248 (0.324)

Rfree

0.266 (0.286)

Number of atoms
Protein

8154
2

Average B factors (Å )

69.6

Ramachandron plot
Favored (%)

93

Allowed (%)

7

Disallowed (%)

0

RMSD Bond lengths(Å)

0.008

1.002
RMSD Bond angles (°)
Rfree was calculated with 5% of the data.
Numbers in parentheses represent values in the highest-resolution shell.
a
Reflections beyond these limits were excluded from refinement after anisotropic correction (a*,
b*, and c* indicate reciprocal cell directions).
b
Completeness after anisotropic correction
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APPENDIX
Appendix A: Sequence alignment of SLO family RCK domains

Sequence alignment of SLO family RCK domains. Human sequences representing the
three main families of SLO channels (hSLO1, hSLO2.2 and hSLO3) are aligned together
with a chicken SLO2 family member (gSLO2.2) and MthK. The alignment of hSLO1 and
MthK is based on their known RCK domain structures. The MthK sequence is repeated
to align to the second RCK domain present in SLO family sequences. In regions with low
sequence identity and significant insertions and deletions, manual alignment was aided
by the SLO1 structure. Two levels of shading indicate sequence identity across all SLO
family members (dark blue) versus identity across only 3 of 4 representative members
(light blue). The same shading is extended to the MthK sequence when identical to the
Slo family sets. The definition of sequence identity was relaxed to include D/E and K/R
substitutions.
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Appendix B: List of point mutations tested on mouse SLO3

E161Q*

H417A

K871A

D162N*

H423A

H877A

K320N

K479A

E880Q

K329N

E502Q

D886N

K332A

K505A

H895A

D343N

K510A

D912N

H354A

H511A

Y920F

K356A

K515A

H923A

E359Q

H516A

R1005A

E363Q

K522A

D1010N#

C382A

K524A

E1011Q#

H383A

H607A

E1012Q#

R401A

R709A

E1013Q#

R402A

R770A

R1020A

*tested in the same

#

construct

construct
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tested in the same
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